Jane Andrews
Adelaide Medical School
Faculty of Health and Medical Sciences
Eligible to supervise Masters and PhD - email supervisor to discuss availability.
Jane Andrews is Head of the IBD Service & Education at the Department of Gastroenterology & Hepatology of The Royal Adelaide Hospital in Australia and a Clinical Professor at the School of Medicine, University of Adelaide.
Professor Andrews has a long clinical research interest and many years practical experience in managing both IBD and other luminal, especially functional, gastrointestinal disorders. She has an interest in clinical audit, value in care, clinical outcomes research and healthcare system delivery.
- My Research
- Career
- Publications
- Grants and Funding
- Teaching
- Supervision
- Professional Activities
- Contact
Professor Andrews is an active researcher in many aspects of clinical Gastroenterology. Particular interests include examining health access, models of care and equity issues in addition to optimising and auditing standard clinical management and trying to improve systems design. Whilst much of her research is focussed on IBD, she also has expertise in Functional GI disease and is also published in hepatology care especially with regard to psychological comorbidities and healthcare utilisation. Her current research collaborators include psychologists, mucosal immunologists, microbiologists, and specialist IBD nurses. Current studies have included Faecal Microbiota Transplantation in ulcerative colitis, examining routine psychological care in IBD, new models of care for FGID and dietary issues in IBD. She also collaborated nationally and internationally via active membership of the ANZ IBD Consortium <www.ANZIBDC.org> . She sits on their management committee and is also a board member of the IBD-Specific charity, Crohn’s Colitis Cure <c-c-cure.org>. Via the ANZIBDC she participates in the international IBD Genetics Consortium work.
Professor Andrews has authored over 120 publications, 3 book chapters and is on the editorial boards of three international journals. She has substantial experience with postgraduate medical education and higher degree supervision.
-
Appointments
Date Position Institution name 2013 - ongoing Clinical Professor University of Adelaide 2009 - 2013 Clinical Ass Professor University of Adelaide 2009 - ongoing Head IBD Service & Education Royal Adelaide Hospital 2007 - 2013 Senior Consultant Gastroenterologist Royal Adelaide Hospital 2006 - 2013 Senior Lecturer Flinders University 2002 - 2008 Clinical Senior Lecturer University of Adelaide 2001 - 2002 Senior Visiting Medical Specialist Lyell McEwin Hospital 2000 - 2007 Senior Consultant Gastroenterologist Repatriation General Hospital 2000 - 2003 Senior Research Fellow University of Adelaide 2000 - 2000 Locum Senior Visiting Medical Specialist Flinders Medical centre -
Awards and Achievements
Date Type Title Institution Name Country Amount 2012 Award SA Health Award for Improving Hospital Care - IBD Service RAH SA Health Australia - -
Education
Date Institution name Country Title 1995 - 2000 University of Adelaide Australia PhD 1994 Royal Australasian College of Physicians Australia FRACP 1986 University of Sydney Australia MBBS 1st class Hons -
Certifications
Date Title Institution name Country 2009 AGAF American Gastroenterological Association - -
Research Interests
-
Journals
Year Citation 2025 Karimi, N., Moore, A. R., Jones, A., Lukin, A., Pipicella, J. L., Williams, A. J., . . . Connor, S. J. (2025). On being on the same page: Predictors of gastroenterologist-patient misalignment in inflammatory bowel disease. Patient Education and Counseling, 130.
2024 Little, R. D., McKenzie, J., Srinivasan, A., Hilley, P., Gilmore, R. B., Chee, D., . . . Sparrow, M. P. (2024). Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial. BMJ Open, 14(7), 8 pages.
2024 Goodsall, T. M., An, Y. K., Andrews, J. M., Begun, J., Friedman, A. B., Lee, A., . . . Bryant, R. V. (2024). Reliability of Intestinal Ultrasound for Evaluating Crohn's Disease Activity Using Point-of-care and Central Reading. Clinical Gastroenterology and Hepatology, S1542-3565(24)00773-0.
2024 Barnes, A., Bryant, R. V., Mukherjee, S., Andrews, J. M., Bampton, P., Fraser, R. J., & Mountifield, R. (2024). Depression influences fatigue in inflammatory bowel disease amongst other factors: a structural modelling approach. Therapeutic Advances in Gastroenterology, 17, 12 pages.
2024 Barnes, A., Toson, B., Bryant, R. V., Mukherjee, S., Andrews, J. M., Spizzo, P., & Mountifield, R. (2024). Latent profiles of fatigue in inflammatory bowel disease. BMC Gastroenterology, 24(1), 7 pages.
Europe PMC12024 Bills, E. R., Dimopoulos, A., Burke, A. L. J., Collins, K. L., Linedale, E. C., Hume, V., . . . Andrews, J. M. (2024). Opportunities to optimise care and choice in joint replacement surgery using a digitally delivered, holistic PreHab pathway. Journal of Orthopaedic Surgery, 32(2), 13 pages.
2024 Barnes, A., Mukherjee, S., Andrews, J. M., Spizzo, P., & Mountifield, R. (2024). Active Inflammatory Bowel Disease Is Associated with Short Sleep Duration via Objective Measures. Digestive Diseases and Sciences, 69(8), 2937-2943.
2024 Reynolds, A. C., Lovato, N., Sletten, T. L., Ferguson, S. A., Katahanas, L., Rajaratnam, S. M., & Adams, R. J. (2024). Assessment and management of sleep disorders in shift workers: Challenges and considerations for general practice. Australian Journal of General Practice, 53(6), 389-393.
2024 Barnes, A., Andrews, J. M., Mukherjee, S., Bryant, R. V., Bampton, P., Fraser, R. J., & Mountifield, R. (2024). Insomnia is common in inflammatory bowel disease (IBD) and is associated with mental health conditions as well as IBD activity. Intestinal Research, 22(1), 104-114.
Scopus5 WoS1 Europe PMC42024 Danese, S., Panaccione, R., Feagan, B. G., Afzali, A., Rubin, D. T., Sands, B. E., . . . D'Haens, G. R. (2024). Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial. The Lancet Gastroenterology and Hepatology, 9(2), 133-146.
Scopus7 WoS1 Europe PMC22024 Majstorovic, M., Chur-Hansen, A., Andrews, J. M., & Burke, A. (2024). Factors associated with progression or non-progression to bariatric surgery in adults: A systematic review. Obesity Reviews, 25(4), 11 pages.
Scopus22024 Lores, T., Mikocka-Walus, A., Andrews, J. M., Evans, S., Lynch, K. D., & Chur-Hansen, A. (2024). Psychological Care for People with Inflammatory Bowel Diseases: Exploring Consumers' Perspectives to Inform Future Service Co-design. Digestive Diseases and Sciences, 69(6), 1979-1989.
2024 Majstorovic, M., Chur-Hansen, A., Andrews, J. M., & Burke, A. L. J. (2024). Bariatric surgeons' views on pre-operative factors associated with improved health-related quality of life following surgery.. Clin Obes, 14(5), e12668.
2023 Akhlaghpour, M., Haritunians, T., More, S. K., Thomas, L. S., Stamps, D. T., Dube, S., . . . Michelsen, K. S. (2023). Genetic coding variant in complement factor B (CFB) is associated with increased risk for perianal Crohn's disease and leads to impaired CFB cleavage and phagocytosis. Gut, 72(11), 2068-2080.
Scopus6 Europe PMC42023 Xia, Y., Wang, K., Chen, Y., & Du, X. (2023). ELAVL1 ameliorates sevoflurane-induced neurotoxicity by inhibiting NLRP3 inflammasome activation. TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 22(12), 2421-2425.
2023 Cao, J., Du, X., Zhao, H., Zhu, C., Li, C., Zhang, X., . . . Ke, X. (2023). Sequentially degradable hydrogel-microsphere loaded with doxorubicin and pioglitazone synergistically inhibits cancer stemness of osteosarcoma. BIOMEDICINE & PHARMACOTHERAPY, 165, 16 pages.
2023 Chen, J. S., Zuo, H. B., Wang, J. X., Xue, Q. G., & Wang, J. S. (2023). Mathematical model of burden distribution in bell-less top blast furnace. Journal of Iron and Steel Research International, 30(2), 216-226.
Scopus22023 Tye-Din, J. A., Daveson, A. J. M., Goel, G., Goldstein, K. E., Hand, H. L., Neff, K. M., . . . Wilson, S. A. (2023). Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study. The Lancet Gastroenterology and Hepatology, 8(5), 446-457.
Scopus18 Europe PMC22023 McNamara, J., Connor, S. J., & Andrews, J. M. (2023). The Evolving Role of Technology in Delivering Patient-centric, Empowered Health Care in Inflammatory Bowel Disease: Patient Experience Using Crohn's Colitis Care e-Health Consumer Platform. Inflammatory Bowel Diseases, 29(9), 1510-1511.
2023 Lores, T., Evans, S., Chur-Hansen, A., Andrews, J. M., Goess, C., Smith, L., . . . Mikocka-Walus, A. A. (2023). Virtual adjunctive gut-directed hypnotherapy for people with Crohn's disease: A randomized controlled pilot and feasibility trial.. Complement Ther Clin Pract, 53, 1-9.
Scopus2 Europe PMC12023 Baumdick, M. E., Niehrs, A., Degenhardt, F., Schwerk, M., Hinrichs, O., Jordan-Paiz, A., . . . Festen, E. A. (2023). HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44<sup>+</sup> Natural Killer Cells in Ulcerative Colitis. Gastroenterology, 165(4), 946-962.e13.
Scopus7 Europe PMC62023 Pipicella, J. L., Vernon-Roberts, A., Dutt, S., Giles, E., Day, A. S., Connor, S. J., & Andrews, J. M. (2023). Co-design and Consultation Ensure Consumer Needs Are Met: Building an eHealth Platform for Children with Inflammatory Bowel Disease. Digestive Diseases and Sciences, 68(12), 4368-4380.
Scopus12023 Linedale, E. C., Bills, E., Dimopoulos, A., Yeoh, J., Nolan, M., Hume, V., . . . Andrews, J. M. (2023). Development of a feasible and acceptable digital prehabilitation pathway to improve elective surgical outcomes. Frontiers in Digital Health, 5, 10 pages.
Scopus2 Europe PMC12023 Louis, E., Resche-Rigon, M., Laharie, D., Satsangi, J., Ding, N., Siegmund, B., . . . Roblin, X. (2023). Withdrawal of infliximab or concomitant immunosuppressant therapy in patients with Crohn's disease on combination therapy (SPARE): a multicentre, open-label, randomised controlled trial. The Lancet Gastroenterology and Hepatology, 8(3), 215-227.
Scopus43 Europe PMC132023 Barnes, A., Andrews, J. M., Mukherjee, S., Bryant, R. V., Bampton, P., Spizzo, P., . . . Mountifield, R. (2023). Simple Novel Screening Tool for Obstructive Sleep Apnea in Inflammatory Bowel Disease. Crohn's and Colitis 360, 5(2), 8 pages.
Scopus3 Europe PMC32023 Lores, T., Krishnaprasad, K., Connor, S. J., Cabaero, A., & Andrews, J. M. (2023). Integration of mental health and quality of life screening tools in an inflammatory bowel disease-specific electronic medical record (Crohn Colitis Care): process and early outcomes. Internal Medicine Journal, 53(1), 136-139.
Scopus3 Europe PMC12023 Barnes, A., Spizzo, P., Bampton, P., Andrews, J. M., Fraser, R. J., Mukherjee, S., & Mountifield, R. (2023). Examining the influence of inflammatory bowel disease medications on sleep quality. JGH Open, 7(3), 190-196.
Scopus4 Europe PMC22023 Burisch, J., Zhao, M., Odes, S., De Cruz, P., Vermeire, S., Bernstein, C. N., . . . Munkholm, P. (2023). The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission. The Lancet Gastroenterology and Hepatology, 8(5), 458-492.
Scopus57 WoS20 Europe PMC262023 Barnes, A., Ooi, S. Y. J., Lynch, K. D., Parthasarathy, N., Bishara, M., Gounder, M., . . . Andrews, J. M. (2023). Proactive Metabolite Testing in Patients on Thiopurine May Yield Long-Term Clinical Benefits in Inflammatory Bowel Disease. Digestive Diseases and Sciences, 68(3), 889-896.
Scopus3 WoS1 Europe PMC32023 Young, E., Jones, E., Thomas, M., Lawrence, M., & Andrews, J. (2023). Poor engagement and adherence predict neoplasia in inflammatory bowel disease: a case-control study. Internal Medicine Journal, 53(5), 731-737.
2023 Lanas, A., Andrews, J. M., Lau, J., Toruner, M., Bromley, S. E., & Gralnek, I. M. (2023). Management of iron-deficiency anemia following acute gastrointestinal hemorrhage: A narrative analysis and review. Journal of Gastroenterology and Hepatology (Australia), 38(1), 23-33.
Scopus5 WoS1 Europe PMC12022 Guzzo, G. L., Mittinty, M. N., Llamas, B., Andrews, J. M., & Weyrich, L. S. (2022). Individuals with Inflammatory Bowel Disease Have an Altered Gut Microbiome Composition of Fungi and Protozoa. Microorganisms, 10(10), 1910.
Scopus5 WoS2 Europe PMC42022 Kaazan, P., Tan, Z., Maiyani, P., Mickenbecker, M., Edwards, S., McIvor, C., & Andrews, J. M. (2022). Weight and BMI Patterns in a Biologicals-Treated IBD Cohort.. Digestive diseases and sciences, 67(12), 5628-5636.
Scopus7 WoS3 Europe PMC52022 Day, A. S., Yao, C. K., Costello, S. P., Ruszkiewicz, A., Andrews, J. M., Gibson, P. R., & Bryant, R. V. (2022). Therapeutic Potential of the 4 Strategies to SUlfide-REduction (4-SURE) Diet in Adults with Mild to Moderately Active Ulcerative Colitis: An Open-Label Feasibility Study. Journal of Nutrition, 152(7), 1690-1701.
Scopus17 WoS8 Europe PMC122022 Duong, T. A., Bryant, R. V., Andrews, J. M., & Lynch, K. D. (2022). Attitudes towards COVID-19 vaccination in patients with inflammatory bowel disease. Internal Medicine Journal, 52(6), 1070-1074.
Scopus5 WoS4 Europe PMC22022 Rubin, D. T., Dotan, I., DuVall, A., Bouhnik, Y., Radford-Smith, G., Higgins, P. D. R., . . . Gonciarz, M. (2022). Etrolizumab versus adalimumab or placebo as induction therapy for moderately to severely active ulcerative colitis (HIBISCUS): two phase 3 randomised, controlled trials. The Lancet Gastroenterology and Hepatology, 7(1), 17-27.
Scopus67 Europe PMC402022 Mortlock, S., Lord, A., Montgomery, G., Zakrzewski, M., Simms, L. A., Krishnaprasad, K., . . . Radford-Smith, G. L. (2022). An Extremes of Phenotype Approach Confirms Significant Genetic Heterogeneity in Patients with Ulcerative Colitis. Journal of Crohn's and Colitis, 17(2), 277-288.
Scopus3 WoS1 Europe PMC32022 Lores, T., & Andrews, J. M. (2022). Routine psychological assessment in inflammatory bowel disease management: practice beyond novelty. Internal Medicine Journal, 52(1), 156-157.
2022 Guzzo, G. L., Andrews, J. M., & Weyrich, L. S. (2022). The Neglected Gut Microbiome: Fungi, Protozoa, and Bacteriophages in Inflammatory Bowel Disease.. Inflamm Bowel Dis, 28(7), 1112-1122.
Scopus26 WoS15 Europe PMC202022 Sandborn, W. J., D'Haens, G. R., Reinisch, W., Panés, J., Chan, D., Gonzalez, S., . . . Feagan, B. G. (2022). Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study. Gastroenterology, 162(6), 1650-1664.e8.
Scopus115 WoS48 Europe PMC542022 Day, A. S., Yao, C. K., Costello, S. P., Andrews, J. M., & Bryant, R. V. (2022). Food-related quality of life in adults with inflammatory bowel disease is associated with restrictive eating behaviour, disease activity and surgery: A prospective multicentre observational study. Journal of Human Nutrition and Dietetics, 35(1), 234-244.
Scopus23 WoS13 Europe PMC122022 Barnes, A., Mountifield, R., Baker, J., Spizzo, P., Bampton, P., Andrews, J. M., . . . Mukherjee, S. (2022). A systematic review and meta-analysis of the prevalence of poor sleep in inflammatory bowel disease.. Sleep advances : a journal of the Sleep Research Society, 3(1), 1-10.
Scopus12 Europe PMC102022 Liu, Z., Julsgaard, M., Zhu, X., Martin, J., Barclay, M. L., Cranswick, N., . . . Ellard, K. (2022). Timing of Live Attenuated Vaccination in Infants Exposed to Infliximab or Adalimumab in Utero: A Prospective Cohort Study in 107 Children. Journal of Crohn's and Colitis, 16(12), 1835-1844.
Scopus8 Europe PMC42022 Dahlan, D., Umar, M. I. A., Sadikin, S. N., Ridwan, J., & Umar, A. A. (2022). Photoelectrical process uplift in Mg-doped-TiO<inf>2</inf> photoanode of dye-sensitized solar cells. Optical Materials, 133, 112976.
Scopus52021 Gu, B., De Gregorio, M., Pipicella, J. L., Vande Casteele, N., Andrews, J. M., Begun, J., . . . Connor, S. (2021). Prospective randomised controlled trial of adults with perianal fistulising Crohn's disease and optimised therapeutic infliximab levels: PROACTIVE trial study protocol.. BMJ open, 11(7), e043921.
Scopus8 WoS3 Europe PMC42021 Day, A. S., Yao, C. K., Costello, S. P., Andrews, J. M., & Bryant, R. V. (2021). Food avoidance, restrictive eating behaviour and association with quality of life in adults with inflammatory bowel disease: A systematic scoping review. Appetite, 167, 16 pages.
Scopus38 WoS15 Europe PMC252021 Wu, Y., Wen, A., Selvanderan, S. P., Xuan, W., Andrews, J. M., Koo, J. H., . . . Connor, S. (2021). Management Decisions in Crohn's Disease Are Changed by Knowledge of Proactive and Reactive Testing of Antitumor Necrosis Factor Drug Levels. Crohn's and Colitis 360, 3(3), 7 pages.
Scopus1 WoS1 Europe PMC12021 Davis, R., Day, A., Barrett, J., Vanlint, A., Andrews, J. M., Costello, S. P., & Bryant, R. V. (2021). Habitual dietary fibre and prebiotic intake is inadequate in patients with inflammatory bowel disease: findings from a multicentre cross-sectional study.. Journal of Human Nutrition and Dietetics, 34(2), 420-428.
Scopus16 WoS12 Europe PMC112021 Goodsall, T. M., Nguyen, T. M., Parker, C. E., Ma, C., Andrews, J. M., Jairath, V., & Bryant, R. V. (2021). Systematic review: Gastrointestinal ultrasound scoring indices for inflammatory bowel disease.. J Crohns Colitis, 15(1), 125-142.
Scopus54 WoS33 Europe PMC282021 Day, A. S., Davis, R., Costello, S. P., Yao, C. K., Andrews, J. M., & Bryant, R. V. (2021). The Adequacy of Habitual Dietary Fiber Intake in Individuals With Inflammatory Bowel Disease: A Systematic Review. Journal of the Academy of Nutrition and Dietetics, 121(4), 688-708.e3.
Scopus21 WoS11 Europe PMC92021 Sammour, T., Schoeman, M., Moore, J. W., Thomas, M. L., Moorcraft, L., & Andrews, J. M. (2021). Clearing a colonoscopy waiting list: how we did it. ANZ J Surg, 91(1-2), 10-12.
2021 Kim, A. H., Girgis, A., De Cruz, P., Siegel, C. A., Karimi, N., Ruban, S. O., . . . Connor, S. J. (2021). Development and feasibility of a web-based decision aid for patients with ulcerative colitis: Qualitative pilot study. Journal of Medical Internet Research, 23(2), 17 pages.
Scopus14 WoS6 Europe PMC72021 Kariyawasam, V. C., Mourad, F. H., Mitrev, N., Paramsothy, S., Selinger, C. P., Katelaris, P. H., . . . Leong, R. W. (2021). Early thiopurine maintenance is associated with reduced proximal disease progression and colectomy rate in ulcerative colitis. European Journal of Gastroenterology and Hepatology, 33(12), 1524-1532.
Scopus7 Europe PMC22021 Barnes, A., Andrews, J., Spizzo, P., & Mountifield, R. (2021). Medication adherence and complementary therapy usage in inflammatory bowel disease patients during the coronavirus disease 2019 pandemic. JGH Open, 5(5), 585-589.
Scopus11 WoS9 Europe PMC112020 Shaikh, A., & Andrews, J. (2020). Is it IBD? Making an accurate and prompt diagnosis. Medicine Today, 21(12), 28-33. 2020 Kaazan, P., Li, T., Seow, W., Bednarz, J., Pipicella, J., Ng, W., . . . Andrews, J. (2020). Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease. JGH Open, 5(9), 1063-1070.
Scopus6 WoS4 Europe PMC32020 Daveson, A. J. M., Tye-Din, J. A., Goel, G., Goldstein, K. E., Hand, H. L., Neff, K. M., . . . Wilson, S. (2020). Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease. Alimentary Pharmacology and Therapeutics, 51(2), 244-252.
Scopus29 Europe PMC142020 Bedrikovetski, S., Liu, J., Dudi Venkata, N. N., Kroon, H., Lewis, M., Lawrence, M., . . . Sammour, T. (2020). Rectal Stump Management After Subtotal Colectomy for Severe Colitis, In or Out? A Retrospective Cohort Study. Indian Journal of Surgery, 82(4), 585-591.
2020 Kaazan, P., Tan, Z., Bednarz, J., Hughes, J., Grafton, R., & Andrews, J. M. (2020). Infliximab-related weight gain in inflammatory bowel disease: associations and financial impacts. Internal medicine journal, 50(9), 1134-1138.
Scopus2 WoS1 Europe PMC22020 Flanagan, E., Gibson, P. R., Wright, E. K., Moore, G. T., Sparrow, M. P., Connell, W., . . . Bell, S. J. (2020). Infliximab, adalimumab and vedolizumab concentrations across pregnancy and vedolizumab concentrations in infants following intrauterine exposure. Alimentary Pharmacology and Therapeutics, 52(10), 1551-1562.
Scopus40 Europe PMC182020 Krishnaprasad, K., Walsh, A., Begun, J., Bell, S., Carter, D., Grafton, R., . . . Andrews, J. M. (2020). Crohn’s Colitis Care (CCCare): bespoke cloud-based clinical management software for inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 55(12), 1419-1426.
Scopus13 WoS11 Europe PMC52020 Tye-Din, J. A., Daveson, A. J. M., Goldstein, K. E., Hand, H. L., Neff, K. M., Goel, G., . . . Wilson, S. (2020). Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease. BMC Medicine, 18(1), 362.
Scopus27 Europe PMC122020 Kim, A. H., Girgis, A., Karimi, N., Sechi, A. J., Descallar, J., Andrews, J. M., . . . Connor, S. J. (2020). A web-based decision aid (myAID) to enhance quality of life, empowerment, decision making, and disease control for patients with ulcerative colitis: Protocol for a cluster randomized controlled trial. JMIR Research Protocols, 9(7), 12 pages.
Scopus10 WoS6 Europe PMC52020 Pulusu, S. S. R., Srinivasan, A., Krishnaprasad, K., Cheng, D., Begun, J., Keung, C., . . . Lawrance, I. C. (2020). Vedolizumab for ulcerative colitis: Real world outcomes from a multicenter observational cohort of Australia and Oxford. WORLD JOURNAL OF GASTROENTEROLOGY, 26(30), 4428-4441.
Scopus18 WoS13 Europe PMC102020 Hamarneh, Z., Robinson, K., Andrews, J., Hunt, R., & Fraser, R. (2020). Transfusion strategies in upper gastrointestinal bleeding management: a review of South Australian hospital practice. Internal Medicine Journal, 50(5), 582-589.
Scopus12020 Gardiner, F. W., Bishop, L., McMahon, K., Nwose, E. U., Connor, S., Begun, J., & Andrews, J. M. (2020). Aeromedical retrievals for gastrointestinal disorders in rural and remote Australia: the need for improved access to specialist advice. Internal Medicine Journal, 50(5), 619-623.
Scopus12020 Mikocka-Walus, A., Massuger, W., Knowles, S. R., Moore, G. T., Buckton, S., Connell, W., . . . Andrews, J. M. (2020). Quality of Care in Inflammatory Bowel Disease: Actual Health Service Experiences Fall Short of the Standards.. Internal medicine journal, 50(10), 1216-1225.
Scopus22 WoS18 Europe PMC192020 Lores, T., Goess, C., Mikocka-Walus, A., Collins, K., Burke, A. L. J., Chur-Hansen, A., . . . Andrews, J. (2020). Integrated Psychological Care Reduces Healthcare Costs at a Hospital-Based Inflammatory Bowel Disease Service. Clinical Gastroenterology and Hepatology, 19(1), 96-103.
Scopus55 WoS38 Europe PMC232020 Haifer, C., Kelly, C. R., Paramsothy, S., Andresen, D., Papanicolas, L. E., McKew, G. L., . . . Leong, R. W. (2020). Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice.. Gut, 69(5), 801-810.
Scopus55 WoS46 Europe PMC362020 Mikocka-Walus, A., Massuger, W., Knowles, S. R., Moore, G. T., Buckton, S., Connell, W., . . . Andrews, J. M. (2020). Psychological distress is highly prevalent in inflammatory bowel disease: A survey of psychological needs and attitudes. JGH Open, 4(2), 166-171.
Scopus34 WoS22 Europe PMC202020 Julsgaard, M., Hvas, C. L., Gearry, R. B., Gibson, P. R., Fallingborg, J., Sparrow, M. P., . . . Bell, S. J. (2020). Anti-TNF Therapy in Pregnant Women With Inflammatory Bowel Disease: Effects of Therapeutic Strategies on Disease Behavior and Birth Outcomes.. Inflammatory bowel diseases, 26(1), 93-102.
Scopus25 WoS17 Europe PMC112020 Linedale, E. C., Mikocka-Walus, A., Gibson, P. R., & Andrews, J. M. (2020). The potential of integrated nurse-led models to improve care for people with functional gastrointestinal disorders: A systematic review. Gastroenterology Nursing, 43(1), 53-64.
Scopus7 WoS5 Europe PMC22019 Mikocka-Walus, A., Prady, S., Pollok, J., Esterman, A., Gordon, A. L., Knowles, S., & Andrews, J. (2019). Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. Cochrane Database of Systematic Reviews, 2019(4), 55 pages.
Scopus3 WoS33 Europe PMC282019 Massuger, W., Moore, G. T. C., Andrews, J. M., Kilkenny, M. F., Reyneke, M., Knowles, S., . . . Pavli, P. (2019). Crohn's & Colitis Australia inflammatory bowel disease audit: measuring the quality of care in Australia.. Internal medicine journal, 49(7), 859-866.
Scopus33 WoS28 Europe PMC192019 Bryant, R., Schultz, C., Ooi, S., Goess, C., Costello, S., Vincent, A., . . . Andrews, J. (2019). Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life. Inflammatory bowel diseases, 25(3), 592-600.
Scopus48 WoS38 Europe PMC312019 Bryant, R. V., Schultz, C. G., Ooi, S., Goess, C., Costello, S. P., Vincent, A. D., . . . Andrews, J. M. (2019). Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life. Inflammatory bowel diseases, 25(6), e62-e63.
2019 Costello, S. P., Conlon, M. A., & Andrews, J. M. (2019). Fecal microbiota transplantation for ulcerative colitis-Reply. JAMA - Journal of the American Medical Association, 321(22), 2240-2241.
Scopus5 WoS5 Europe PMC42019 Bedrikovetski, S., Dudi Venkata, N., Kroon, H. M., Liu, J., Andrews, J. M., Lewis, M., . . . Sammour, T. (2019). Systematic review of rectal stump management during and after emergency total colectomy for acute severe ulcerative colitis. ANZ J Surg, 89(12), 1556-1560.
Scopus12 WoS6 Europe PMC42019 Kariyawasam, V. C., Kim, S., Mourad, F. H., Selinger, C. P., Katelaris, P. H., Brian Jones, D., . . . Leong, R. W. (2019). Comorbidities Rather Than Age Are Associated With the Use of Immunomodulators in Elderly-onset Inflammatory Bowel Disease.. Inflammatory bowel diseases, 25(8), 1390-1398.
Scopus21 Europe PMC72019 Costello, S. P., Hughes, P. A., Waters, O., Bryant, R. V., Vincent, A. D., Blatchford, P., . . . Andrews, J. M. (2019). Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA - Journal of the American Medical Association, 321(2), 156-164.
Scopus608 WoS440 Europe PMC3522019 Lores, T., Goess, C., Mikocka-Walus, A., Collins, K. L., Burke, A. L. J., Chur-Hansen, A., . . . Andrews, J. M. (2019). Integrated psychological care is needed, welcomed and effective in ambulatory Inflammatory Bowel Disease management: Evaluation of a new initiative.. Journal of Crohn's & colitis, 13(7), 819-827.
Scopus51 WoS36 Europe PMC182019 Walker, G. J., Harrison, J. W., Heap, G. A., Voskuil, M. D., Andersen, V., Anderson, C. A., . . . Gee, I. (2019). Association of Genetic Variants in NUDT15 with Thiopurine-Induced Myelosuppression in Patients with Inflammatory Bowel Disease. JAMA - Journal of the American Medical Association, 321(8), 753-761.
Scopus117 WoS97 Europe PMC732019 An, Y. -K., Prince, D., Gardiner, F., Neeman, T., Linedale, E. C., Andrews, J. M., . . . Begun, J. (2019). Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysis.. The Medical journal of Australia, 211(10), 7 pages.
Scopus19 WoS15 Europe PMC52019 Romagnoni, A., Jégou, S., Van Steen, K., Wainrib, G., Hugot, J. P., Peyrin-Biroulet, L., . . . Sharma, Y. (2019). Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data. Scientific Reports, 9(1), 18 pages.
Scopus79 WoS59 Europe PMC412019 Young, E., Lawrence, M., Thomas, M., & Andrews, J. (2019). Gastrointestinal neoplasia in patients with inflammatory bowel disease: Opportunities to enhance preventative strategies. JGH Open, 3(6), 513-517.
Scopus2 WoS22019 Liu, J., Andrews, J. M., Sammour, T., Bryant, R. V., Grafton, R., Simpson, E., . . . Nixon, C. (2019). Benefits of exclusive enteral nutrition in adults with complex active Crohn's disease: A case series of 13 consecutive patients. Crohn's and Colitis 360, 1(3), 1-7.
Scopus2 WoS12018 Rivas, M. A., Avila, B. E., Koskela, J., Huang, H., Stevens, C., Pirinen, M., . . . Gearry, R. (2018). Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population. PLoS Genetics, 14(5), e1007329.
Scopus51 Europe PMC432018 Flanagan, E., Gibson, P. R., Begun, J., Ghaly, S., Garg, M., Andrews, J. M., . . . Bell, S. J. (2018). Letter: vedolizumab drug concentrations in neonates following intrauterine exposure. Alimentary Pharmacology and Therapeutics, 48(11-12), 1328-1330.
Scopus15 Europe PMC72018 Mikocka-Walus, A., & Andrews, J. M. (2018). It is high time to examine the psyche while treating IBD. Nature Reviews Gastroenterology and Hepatology, 15(6), 329-330.
Scopus15 WoS11 Europe PMC92018 Bryant, R., Schultz, C., Ooi, S., Goess, C., Costello, S., Vincent, A., . . . Andrews, J. (2018). Obesity in inflammatory bowel disease: gains in adiposity despite high prevalence of Myopenia and Osteopenia. Nutrients, 10(9), 1192-1-1192-17.
Scopus57 WoS44 Europe PMC292018 Knowles, S., Andrews, J. M., & Porter, A. (2018). Predictors of Impaired Mental Health and Support Seeking in Adults With Inflammatory Bowel Disease: An Online Survey.. Gastroenterol Nurs, 41(1), 38-46.
Scopus14 Europe PMC112018 Wright, E., Kamm, M., De Cruz, P., Hamilton, A., Selvaraj, F., Princen, F., . . . Connell, W. (2018). Anti-TNF therapeutic drug monitoring in postoperative Crohn's disease. Journal of Crohn's and Colitis, 12(6), 653-661.
Scopus21 WoS20 Europe PMC152018 Ferman, M., Lim, A. H., Hossain, M., Siow, G. W., & Andrews, J. M. (2018). Multidisciplinary team meetings appear to be effective in inflammatory bowel disease management: an audit of process and outcomes. Internal Medicine Journal, 48(9), 1102-1108.
Scopus30 WoS16 Europe PMC202018 Roberts, R. L., Wallace, M. C., Seinen, M. L., van Bodegraven, A. A., Krishnaprasad, K., Jones, G. T., . . . Barclay, M. L. (2018). Nonsynonymous polymorphism in guanine monophosphate synthetase is a risk factor for unfavorable thiopurine metabolite ratios in patients with inflammatory bowel disease. Inflammatory Bowel Diseases, 24(12), 2606-2612.
Scopus6 Europe PMC12018 Momozawa, Y., Dmitrieva, J., Théâtre, E., Deffontaine, V., Rahmouni, S., Charloteaux, B., . . . Huang, H. (2018). IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes. Nature Communications, 9(1), 18 pages.
Scopus139 WoS114 Europe PMC1132018 Linedale, E., Mikocka-Walus, A., Vincent, A., Gibson, P., & Andrews, J. (2018). Performance of an algorithm-based approach to the diagnosis and management of functional gastrointestinal disorders: A pilot trial. Neurogastroenterology and Motility, 30(1), e13243-1-e13243-10.
Scopus7 WoS7 Europe PMC32018 Mavrangelos, C., Campaniello, M., Andrews, J., Bampton, P., & Hughes, P. (2018). Longitudinal analysis indicates symptom severity influences immune profile in irritable bowel syndrome. Gut, 67(2), 398-399.
Scopus7 WoS7 Europe PMC62018 Bryant, R., Costello, S., Schoeman, S., Sathananthan, D., Knight, E., Lau, S. -Y., . . . Andrews, J. (2018). Limited uptake of ulcerative colitis 'treat to target' recommendations in real-world practice. Journal of gastroenterology and hepatology, 33(3), 599-607.
Scopus36 WoS26 Europe PMC192017 Costello, S. P., Soo, W., Bryant, R. V., Jairath, V., Hart, A. L., & Andrews, J. M. (2017). Editorial: faecal microbiota transplantation for ulcerative colitis—not quite there yet? Authors’ reply. Alimentary Pharmacology and Therapeutics, 46(6), 631-632.
2017 Chen, G., Lee, S., Montgomery, G., Wray, N., Visscher, P., Gearry, R., . . . Moser, G. (2017). Performance of risk prediction for inflammatory bowel disease based on genotyping platform and genomic risk score method. BMC Medical Genetics, 18(1), 94-1-94-11.
Scopus37 WoS29 Europe PMC242017 Costello, S., Soo, W., Bryant, R., Jairath, V., Hart, A., & Andrews, J. (2017). Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Alimentary Pharmacology and Therapeutics, 46(3), 213-224.
Scopus215 WoS175 Europe PMC1392017 Andrews, J. M. (2017). Editorial: yoga for QoL in ulcerative colitis—any better than other supportive activities?. Alimentary Pharmacology and Therapeutics, 46(2), 201-202.
Scopus2 Europe PMC12017 Mikocka-Walus, A., Fielder, A., Prady, S. L., Esterman, A. J., Knowles, S., & Andrews, J. M. (2017). Adjuvant therapy with antidepressants for the management of inflammatory bowel disease. Cochrane Database of Systematic Reviews, 2017(7).
Scopus432017 Mitrev, N., Vande Casteele, N., Seow, C. H., Andrews, J. M., Connor, S. J., Moore, G. T., . . . Leong, R. W. (2017). Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics, 46(11-12), 1037-1053.
Scopus248 WoS192 Europe PMC1192017 Linedale, E. C., & Andrews, J. M. (2017). Diagnosis and management of irritable bowel syndrome: a guide for the generalist. Medical Journal of Australia, 207(7), 309-315.
Scopus23 WoS11 Europe PMC92017 Linedale, E. C., Shahzad, M. A., Kellie, A. R., Mikocka-Walus, A., Gibson, P. R., & Andrews, J. M. (2017). Referrals to a tertiary hospital: A window into clinical management issues in functional gastrointestinal disorders. JGH Open, 1(3), 84-91.
Scopus12 WoS10 Europe PMC42017 Shah, A., Talley, N., Walker, M., Koloski, N., Morrison, M., Burger, D., . . . Holtmann, G. (2017). Is There a Link Between H. Pylori and the Epidemiology of Crohn’s Disease?. Digestive Diseases and Sciences, 62(9), 2472-2480.
Scopus13 WoS11 Europe PMC62017 Lawrance, I., Baird, A., Lightower, D., Radford-Smith, G., Andrews, J., & Connor, S. (2017). Efficacy of Rectal Tacrolimus for Induction Therapy in Patients With Resistant Ulcerative Proctitis. Clinical Gastroenterology and Hepatology, 15(8), 1248-1255.
Scopus47 WoS33 Europe PMC182017 Bye, W. A., Sparrow, M. P., Connor, S. J., Andrews, J. M., Ellard, K., Ng, W., . . . Walsh, A. J. (2017). The need for better preventative strategies for inflammatory bowel disease patients at risk of herpes zoster virus. Internal Medicine Journal, 47(11), 1263-1269.
Scopus2 WoS22017 Fazal, M., Andrews, J., Thomas, J., & Saffouri, E. (2017). Inpatient iron deficiency detection and management: how do general physicians and gastroenterologists perform in a tertiary care hospital?. Internal Medicine Journal, 47(8), 928-932.
Scopus1 WoS2 Europe PMC12017 Ben-Horin, S., Andrews, J., Katsanos, K., Rieder, F., Steinwurz, F., Karmiris, K., . . . Bernstein, C. (2017). Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice. World Journal of Gastroenterology, 23(16), 2995-3002.
Scopus8 WoS8 Europe PMC72017 Doecke, J., Hartnell, F., Bampton, P., Bell, S., Mahy, G., Grover, Z., . . . Radford-Smith, G. (2017). Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study. Alimentary Pharmacology and Therapeutics, 45(4), 542-552.
Scopus35 Europe PMC262017 Daveson, A. J. M., Ee, H. C., Andrews, J. M., King, T., Goldstein, K. E., Dzuris, J. L., . . . Anderson, R. P. (2017). Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study. EBioMedicine, 26, 78-90.
Scopus50 Europe PMC242017 Goel, G., King, T., Daveson, A. J., Andrews, J. M., Krishnarajah, J., Krause, R., . . . Anderson, R. P. (2017). Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies. The Lancet Gastroenterology and Hepatology, 2(7), 479-493.
Scopus117 Europe PMC552017 Bryant, R. V., Costello, S. P., Tee, D., Mountifield, R., Schoeman, S., Schoeman, M., . . . Andrews, J. M. (2017). TREAT TO TARGET: RECOMMENDATIONS IN ULCERATIVE COLITIS (UC) IN PRACTICE: CLINICIAN PERCEPTIONS AND POTENTIAL BARRIERS. GASTROENTEROLOGY, 152(5), S772.
2017 Mikocka-Walus, A., Hughes, P. A., Bampton, P., Gordon, A., Campaniello, M. A., Mavrangelos, C., . . . Andrews, J. M. (2017). Fluoxetine for maintenance of remission and to improve quality of life in patients with Crohn's disease: a pilot randomised placebo-controlled trial. Journal of Crohn's & colitis, 11(4), 509-514.
Scopus44 WoS35 Europe PMC272017 Mikocka-Walus, A., Bampton, P., Hetzel, D., Hughes, P., Esterman, A., & Andrews, J. (2017). Cognitive-behavioural therapy for inflammatory bowel disease: 24-month data from a randomised controlled trial. International Journal of Behavioral Medicine, 24(1), 127-135.
Scopus52 WoS41 Europe PMC392017 Hillock, N. T., Heard, S., Kichenadasse, G., Hill, C. L., & Andrews, J. (2017). Infliximab for ipilimumab-induced colitis: A series of 13 patients. Asia-Pacific Journal of Clinical Oncology, 13(5), e284-e290.
Scopus32 WoS19 Europe PMC132017 Hamilton, A., Kamm, M., De Cruz, P., Wright, E., Selvaraj, F., Princen, F., . . . Connell, W. (2017). Serologic antibodies in relation to outcome in postoperative Crohn's disease. Journal of Gastroenterology and Hepatology, 32(6), 1195-1203.
Scopus25 WoS16 Europe PMC152016 An, V., Cohen, L., Lawrence, M., Thomas, M., Andrews, J., & Moore, J. (2016). Early surgery in Crohn's disease a benefit in selected cases.. World journal of gastrointestinal surgery, 8(7), 492-500.
Europe PMC162016 Andrews, J. M., Costello, S. P., Agarwal, A. K., Bampton, P., Beswick, L., Connor, S., . . . Walsh, A. J. (2016). Conflict of interest: Real and perceived - a more mature consideration is needed. Internal Medicine Journal, 46(3), 377-379.
2016 Hsieh, A. H. C., Ferman, M., Brown, M. P., & Andrews, J. M. (2016). Vedolizumab: a novel treatment for ipilimumab-induced colitis. BMJ Case Reports, 2016, bcr2016216641-1-bcr2016216641-4.
Scopus45 Europe PMC232016 Andrews, J. M. (2016). How to fund IBD nurses. Journal of Gastroenterology and Hepatology (Australia), 31(S1), 43.
Scopus3 Europe PMC22016 Hughes, P., Costello, S., Bryant, R., & Andrews, J. (2016). Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications. American Journal of Physiology, 311(3), G501-G513.
Scopus21 WoS15 Europe PMC132016 McCallum, S., Andrews, J., Gaughwin, M., Turnbull, D., & Mikocka-Walus, A. (2016). Patient satisfaction with treatment for alcohol use disorders: comparing patients with and without severe mental health symptoms. Patient Preference and Adherence, 10, 1489-1500.
Scopus6 WoS6 Europe PMC52016 Linedale, E., Chur-Hansen, A., Mikocka-Walus, A., Gibson, P., & Andrews, J. (2016). Uncertain diagnostic language affects further studies, endoscopies, and repeat consultations for patients with functional gastrointestinal disorders. Clinical Gastroenterology and Hepatology, 14(12), 1735-1741.e1.
Scopus27 WoS23 Europe PMC112016 Bodea, C. A., Neale, B. M., Ripke, S., Barclay, M., Peyrin-Biroulet, L., Chamaillard, M., . . . Zhao, H. (2016). A method to exploit the structure of genetic ancestry space to enhance case-control studies. American Journal of Human Genetics, 98(5), 857-868.
Scopus12 Europe PMC112016 Chen, J. H., Andrews, J. M., Kariyawasam, V., Moran, N., Gounder, P., Collins, G., . . . Leong, R. W. (2016). Review article: Acute severe ulcerative colitis - Evidence-based consensus statements. Alimentary Pharmacology and Therapeutics, 44(2), 127-144.
Scopus67 WoS52 Europe PMC362016 Costello, S., Tucker, E., La Brooy, J., Schoeman, M., & Andrews, J. (2016). Establishing a fecal microbiota transplant service for the treatment of Clostridium difficile infection. Clinical Infectious Diseases, 62(7), 908-914.
Scopus90 WoS78 Europe PMC562016 Mikocka-Walus, A., Andrews, J. M., & Bampton, P. (2016). Cognitive behavioral therapy for IBD. Inflammatory Bowel Diseases, 22(2), E5-E6.
Scopus8 WoS6 Europe PMC62016 Bennett, A. L., Moore, D., Bampton, P. A., Bryant, R. V., & Andrews, J. M. (2016). Outcomes and patients' perspectives of transition from paediatric to adult care in inflammatory bowel disease. World Journal of Gastroenterology, 22(8), 2611-2620.
Scopus32 WoS29 Europe PMC192016 Bennett, A. L., Buckton, S., Lawrance, I., Leong, R. W., Moore, G., & Andrews, J. M. (2016). Ulcerative colitis outpatient management: development and evaluation of tools to support primary care practitioners (vol 45, pg 1254, 2015). INTERNAL MEDICINE JOURNAL, 46(2), 244.
2016 Julsgaard, M., Christensen, L., Gibson, P., Gearry, R., Fallingborg, J., Hvas, C., . . . Bell, S. (2016). Concentrations of adalimumab and infliximab in mothers and newborns, and effects on infection. Gastroenterology, 151(1), 110-119.
Scopus256 WoS209 Europe PMC1272016 Elnawsra, O., Fok, I., Sparrow, M., Gibson, P., Andrews, J., & Connor, S. (2016). Faecal calprotectin: Current usage and perceived beneficial effects of third-party funding on rates of colonoscopy by Australian gastroenterologists. Internal Medicine Journal, 46(5), 590-595.
Scopus7 WoS5 Europe PMC32016 Mikocka-Walus, A., & Andrews, J. (2016). Experience with and attitudes toward psychotherapy and antidepressants among patients with inflammatory bowel disease and functional gastrointestinal disorders. Gastroenterology Nursing, 39(4), 278-286.
Scopus8 WoS6 Europe PMC32016 Andrews, J. M. (2016). Barriers to reforming low-value care. Medical Journal of Australia, 204(5), 187.
Scopus12016 Cleynen, I., Boucher, G., Jostins, L., Schumm, L., Zeissig, S., Ahmad, T., . . . Lees, C. (2016). Inherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study. Lancet, 387(10014), 156-167.
Scopus584 WoS486 Europe PMC3822016 Williamson, K., Gill, M., Andrews, J., & Harley, H. (2016). Inpatient healthcare utilisation in patients with alcoholic liver disease: what are the costs and outcomes?. Internal Medicine Journal, 46(12), 1407-1413.
Scopus4 WoS4 Europe PMC22016 Mikocka-Walus, A., Ahl, A., Gordon, A., & Andrews, J. (2016). A cognitive behavioural therapy booklet for anxiety in functional gastrointestinal disorders: patient and health practitioner perspectives. Psychotherapy Research, 26(2), 164-177.
Scopus3 WoS3 Europe PMC12016 Mccallum, S., Mikocka-Walus, A., Gaughwin, M., Andrews, J., & Turnbull, D. (2016). 'I'm a sick person, not a bad person': Patient experiences of treatments for alcohol use disorders. Health Expectations, 19(4), 828-841.
Scopus28 WoS22 Europe PMC142016 McCombie, A., Gearry, R., Andrews, J., Mulder, R., & Mikocka-Walus, A. (2016). Does computerized cognitive behavioral therapy help people with inflammatory bowel disease? A randomized controlled trial. Inflammatory Bowel Diseases, 22(1), 171-181.
Scopus67 WoS53 Europe PMC432015 De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., Gorelik, A., . . . Desmond, P. V. (2015). Efficacy of thiopurines and adalimumab in preventing Crohn's disease recurrence in high-risk patients - a POCER study analysis. Alimentary Pharmacology and Therapeutics, 42(7), 867-879.
Scopus112 WoS87 Europe PMC612015 Costello, S., Conlon, M., Vuaran, M., Roberts-Thomson, I., & Andrews, J. (2015). Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: Clinical efficacy and bacterial viability data. Alimentary Pharmacology and Therapeutics, 42(8), 1011-1018.
Scopus110 WoS88 Europe PMC762015 Bennett, A., Buckton, S., Lawrance, I., Leong, R., Moore, G., & Andrews, J. (2015). Ulcerative colitis outpatient management: Development and evaluation of tools to support primary care practitioners. Internal Medicine Journal, 45(12), 1254-1266.
WoS12015 McCombie, A., Gearry, R., Andrews, J., Mikocka-Walus, A., & Mulder, R. (2015). Computerised cognitive behavioural therapy for psychological distress in patients with physical illnesses: a systematic review. Journal of Clinical Psychology in Medical Settings, 22(1), 20-44.
Scopus33 WoS30 Europe PMC232015 Reeve, E., Andrews, J., Wiese, M., Hendrix, I., Roberts, M., & Shakib, S. (2015). Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors. Annals of Pharmacotherapy, 49(1), 29-38.
Scopus73 WoS51 Europe PMC442015 De Cruz, P., Kamm, M., Hamilton, A., Ritchie, K., Krejany, E., Gorelik, A., . . . Desmond, P. (2015). Crohn's disease management after intestinal resection: a randomised trial. The Lancet, 385(9976), 1406-1417.
Scopus485 WoS382 Europe PMC2552015 Keeton, R., Mikocka-Walus, A., & Andrews, J. (2015). Concerns and worries in people living with inflammatory bowel disease (IBD): a mixed methods study. Journal of Psychosomatic Research, 78(6), 573-578.
Scopus56 WoS48 Europe PMC322015 Roberts, R. L., Wallace, M. C., Seinen, M. L., Krishnaprasad, K., Chew, A., Lawrance, I., . . . Barclay, M. L. (2015). Erratum: PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease (American Journal of Gastroenterology (2014) 109 (926) DOI: 10.1038/ajg.2014.89). American Journal of Gastroenterology, 110(1), 204.
2015 Wright, E., Kamm, M., De Cruz, P., Hamilton, A., Ritchie, K., Krejany, E., . . . Gearry, R. (2015). Measurement of fecal calprotectin improves monitoring and detection of recurrence of Crohn's disease after surgery. Gastroenterology, 148(5), 938-947.e1.
Scopus243 WoS199 Europe PMC1372015 Williamson, K., Steveling, K., Holtmann, G., Schoeman, M., & Andrews, J. (2015). Clinical triage for colonoscopy is useful in young women. Internal Medicine Journal, 45(5), 492-496.
Scopus7 WoS6 Europe PMC22015 Bryant, R., Ooi, S., Schultz, C., Goess, C., Grafton, R., Hughes, J., . . . Andrews, J. (2015). Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Alimentary Pharmacology and Therapeutics, 41(9), 895-906.
Scopus111 WoS92 Europe PMC682015 Wright, E., Kamm, M., De Cruz, P., Hamilton, A., Ritchie, K., Krejany, E., . . . Desmond, P. (2015). Effect of intestinal resection on quality of life in Crohn's disease. Journal of Crohn's and Colitis, 9(6), 452-462.
Scopus30 WoS24 Europe PMC212015 Mountifield, R., Andrews, J., Mikocka-Walus, A., & Bampton, P. (2015). Doctor communication quality and friends' attitudes influence complementary medicine use in inflammatory bowel disease. World Journal of Gastroenterology, 21(12), 3663-3670.
Scopus37 WoS31 Europe PMC232015 Bennett, A., Munkholm, P., & Andrews, J. (2015). Tools for primary care management of inflammatory bowel disease: do they exist?. World Journal of Gastroenterology, 21(15), 4457-4465.
Scopus22 WoS17 Europe PMC162015 Mikocka-Walus, A., Bampton, P., Hetzel, D., Hughes, P., Esterman, A., & Andrews, J. (2015). Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial. BMC Gastroenterology, 15(1), 54-1-54-12.
Scopus63 WoS49 Europe PMC342015 Stephens, M., Hourigan, L., Appleyard, M., Ostapowicz, G., Schoeman, M., Desmond, P., . . . Holtmann, G. (2015). Non-physician endoscopists: a systematic review. World Journal of Gastroenterology, 21(16), 5056-5071.
Scopus17 WoS13 Europe PMC82015 Costello, S. P., Chung, A., Andrews, J. M., & Fraser, R. J. (2015). Fecal microbiota transplant for Clostridium difficile colitis-induced toxic megacolon. American Journal of Gastroenterology, 110(5), 775-777.
Scopus22 WoS22 Europe PMC132015 Bryant, R. V., & Andrews, J. M. (2015). Letter: low muscle mass and disordered eating as causes of osteopenia in inflammatory bowel disease - authors' reply. Alimentary Pharmacology and Therapeutics, 41(12), 1304-1305.
Scopus1 WoS1 Europe PMC12015 Costello, S., Ghaly, S., Beswick, L., Pudipeddi, A., Agarwal, A., Sechi, A., . . . Andrews, J. (2015). Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patients. Internal Medicine Journal, 45(6), 659-666.
Scopus4 WoS3 Europe PMC32015 Goyette, P., Boucher, G., Mallon, D., Ellinghaus, E., Jostins, L., Huang, H., . . . Lee, J. C. (2015). High-density mapping of the MHC identifies a shared role for HLA-DRB1∗01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis. Nature Genetics, 47(2), 172-179.
Scopus249 Europe PMC1942015 Williamson, K. D., Schoeman, M., & Andrews, J. M. (2015). Author reply. Internal Medicine Journal, 45(11), 1199.
2015 Bryant, R. V., Costello, S. P., & Andrews, J. M. (2015). Editorial: Untangling symptoms from mucosal healing in UC - A note of caution for patient-reported outcomes. Alimentary Pharmacology and Therapeutics, 42(11-12), 1327-1328.
Scopus1 WoS1 Europe PMC12015 Stewart, B., Turnbull, D., Mikocka-Walus, A., Harley, H., & Andrews, J. (2015). An aggravated trajectory of depression and anxiety co-morbid with hepatitis C: a within-groups study of 61 Australian outpatients. Clinical Practice and Epidemiology in Mental Health, 11(1), 174-179.
Scopus3 Europe PMC12015 Ghaly, S., Costello, S., Beswick, L., Pudipeddi, A., Agarwal, A., Sechi, A., . . . Andrews, J. (2015). Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response. Internal Medicine Journal, 45(2), 170-177.
Scopus7 WoS6 Europe PMC42015 McCallum, S., Mikocka-Walus, A., Turnbull, D., & Andrews, J. (2015). Continuity of care in dual diagnosis treatment: definitions, applications, and implications. Journal of Dual Diagnosis, 11(3-4), 217-232.
Scopus19 WoS15 Europe PMC52015 Kashkooli, S., Andrews, J., Roberts, M., Selinger, C., & Leong, R. (2015). Inflammatory bowel disease-specific pregnancy knowledge of gastroenterologists against general practitioners and obstetricians. United European Gastroenterology Journal, 3(5), 462-470.
Scopus26 WoS21 Europe PMC132015 Andrews, J. M. (2015). Editorial: Functional gastrointestinal disorders and body mass index. Alimentary Pharmacology and Therapeutics, 41(11), 1211-1212.
2015 Lunney, P., Kariyawasam, V., Wang, R., Middleton, K., Huang, T., Selinger, C., . . . Leong, R. (2015). Smoking prevalence and its influence on disease course and surgery in Crohn's disease and ulcerative colitis. Alimentary Pharmacology and Therapeutics, 42(1), 61-70.
Scopus79 Europe PMC512015 Bennett, A., Wichmann, M., Chin, J., Andrews, J., & Bampton, P. (2015). Rural inflammatory bowel disease care in Australia: disease outcomes and
perceived barriers to optimal care. Health systems and policy research, 2(2), 1-10.
2014 Crocker, K., Chur-Hansen, A., & Andrews, J. (2014). Irritable bowel syndrome : Reply. Australian Family Physician, 43(1-2), 9. 2014 Kariyawasam, V. C., Selinger, C. P., Katelaris, P. H., Jones, D. B., McDonald, C., Barr, G., . . . Leong, R. W. (2014). Early use of thiopurines or methotrexate reduces major abdominal and perianal surgery in Crohn's disease. Inflammatory Bowel Diseases, 20(8), 1382-1390.
Scopus48 Europe PMC292014 Andrews, J., & Costello, S. (2014). The emerging role of faecal microbiota transplantation. Medicine Today, 15(7), 62-64.
Scopus12014 Ooi, S. Y. J., & Andrews, J. M. (2014). Ulcerative colitis: Unravelling the uncertainty in diagnosis and management. Medicine Today, 15(9), 36-44. 2014 Pan, W. J., Köck, K., Rees, W. A., Sullivan, B. A., Evangelista, C. M., Yen, M., . . . Borie, D. C. (2014). Clinical pharmacology of AMG 181, a gut-specific human anti-α4β7 monoclonal antibody, for treating inflammatory bowel diseases. British Journal of Clinical Pharmacology, 78(6), 1315-1333.
Scopus29 Europe PMC212014 Costello, S., La Brooy, J., Tucker, E., Holloway, R., Schoeman, M., & Andrews, J. M. (2014). Establishment of a fecal microbiota transplant service for the treatment of recurrent <i>Clostridium difficile</i> colitis in the Australian public hospital setting. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 29, 134. 2014 Stewart, B., Sindicich, N., Turnbull, D., Andrews, J., & Mikocka-Walus, A. (2014). Changes in Australian injecting drug users’ mental health problems and service uptake from 2006-2012. Advances in Dual Diagnosis, 7(4), 151-161.
2014 Julsgaard, M., Christensen, L. A., Fallingborg, J., Gearry, R., Radford-Smith, G., Walsh, A., . . . Bell, S. J. (2014). Intra-uterine ExposuRe to Anti-TNF-alpha therapy (ERA study): Infliximab and adalimumab cord blood levels correlate with maternal levels at birth. JOURNAL OF CROHNS & COLITIS, 8, S34-S35.
WoS12014 Wright, E., Williams, J., Andrews, J., Day, A., Gearry, R., Bampton, P., . . . De Cruz, P. (2014). Perspectives of paediatric and adult gastroenterologists on transfer and transition care of adolescents with inflammatory bowel disease. Internal Medicine Journal, 44(5), 490-496.
Scopus47 WoS39 Europe PMC342014 Heap, G., Weedon, M., Bewshea, C., Singh, A., Chen, M., Satchwell, J., . . . Ahmad, T. (2014). HLA-DQA1-HLA-DRB1 variants confer susceptibility to pancreatitis induced by thiopurine immunosuppressants. Nature Genetics, 46(10), 1131-1134.
Scopus166 WoS146 Europe PMC1112014 Hughes, P., Moretta, M., Lim, A., Grasby, D., Bird, D., Brierley, S., . . . Krumbiegel, D. (2014). Immune derived opioidergic inhibition of viscerosensory afferents is decreased in Irritable Bowel Syndrome patients. Brain, Behavior, and Immunity, 42, 191-203.
Scopus40 WoS37 Europe PMC292014 Martindale, F., Mikocka-Walus, A., Walus, B., Keage, H., & Andrews, J. (2014). The effects of a designer music intervention on patients' anxiety, pain, and experience of colonoscopy: a short report on a pilot study. Gastroenterology Nursing, 37(5), 338-342.
Scopus18 WoS17 Europe PMC82014 Rollbusch, N., Mikocka-Walus, A., & Andrews, J. (2014). The experience of anxiety in colonoscopy outpatients: a mixed-method study. Gastroenterology Nursing, 37(2), 166-175.
Scopus18 WoS11 Europe PMC82014 Mountifield, R., Andrews, J., Mikocka-Walus, A., & Bampton, P. (2014). Covert dose reduction is a distinct type of medication non-adherence observed across all care settings in Inflammatory Bowel Disease. Journal of Crohn's & Colitis, 8(12), 1723-1729.
Scopus21 WoS17 Europe PMC62014 Mikocka-Walus, A., Andrews, J., Rampton, D., Goodhand, J., van der Woude, J., & Bernstein, C. (2014). How can we improve models of care in inflammatory bowel disease? An international survey of IBD health professionals. Journal of Crohn's and Colitis, 8(12), 1668-1674.
Scopus43 WoS37 Europe PMC322014 Roberts, R. L., Wallace, M. C., Seinen, M. L., Krishnaprasad, K., Chew, A., Lawrance, I., . . . Barclay, M. L. (2014). PACSIN2 does not influence thiopurine-related toxicity in patients with inflammatory bowel disease. American Journal of Gastroenterology, 109(6), 925-927.
Scopus8 Europe PMC62014 Ooi, S. Y. J., & Andrews, J. M. (2014). Commentary: the association between high dietary intake of docosahexaenoic acid and reduced risk of Crohn's disease. Alimentary Pharmacology and Therapeutics, 39(11), 1331-1332.
Scopus1 WoS12014 Mountifield, R., Andrews, J., & Bampton, P. (2014). It IS worth the effort: patient knowledge of reproductive aspects of inflammatory bowel disease improves dramatically after a single group education session. Journal of Crohn's and Colitis, 8(8), 796-801.
Scopus51 WoS41 Europe PMC262014 Mountifield, R., Bampton, P., Prosser, R., Mikocka-Walus, A., & Andrews, J. (2014). Colon cancer surveillance in inflammatory bowel disease: unclear gain but no psychological pain?. Internal Medicine Journal, 44(2), 131-138.
Scopus8 WoS6 Europe PMC22014 Selinger, C., Andrews, J., Titman, A., Norton, I., Jones, D., McDonald, C., . . . Leong, R. (2014). Long-term follow-up reveals low incidence of colorectal cancer, but frequent need for resection, among Australian patients with inflammatory bowel disease. Clinical Gastroenterology and Hepatology, 12(4), 644-650.
Scopus78 WoS62 Europe PMC402014 Mikocka-Walus, A., & Andrews, J. (2014). Attitudes towards antidepressants among people living with inflammatory bowel disease: an online Australia-wide survey. Journal of Crohn's and Colitis, 8(4), 296-303.
Scopus15 WoS16 Europe PMC102014 Gibson, P., Vaizey, C., Black, C., Nicholls, R., Weston, A., Bampton, P., . . . Fan, T. (2014). Relationship between disease severity and quality of life and assessment of health care utilization and cost for ulcerative colitis in Australia: a cross-sectional, observational study. Journal of Crohn's and Colitis, 8(7), 598-606.
Scopus97 WoS90 Europe PMC682013 Lawrance, I., Murray, K., Batman, B., Gearry, R., Grafton, R., Krishnaprasad, K., . . . Hanigan, K. (2013). Crohn's disease and smoking: is it ever too late to quit?. Journal of Crohn's and Colitis, 7(12), e665-e671.
Scopus39 Europe PMC292013 Bryant, R., Trott, M., Bartholomeusz, F., & Andrews, J. (2013). Systematic review: Body composition in adults with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 38(3), 213-225.
Scopus144 WoS116 Europe PMC862013 Bryant, R., Trott, M., Bennett, A., Bampton, P., Moore, D., & Andrews, J. (2013). Transition of care in inflammatory bowel disease: mind the gap! Theory, practice and recommendations for an Australian context. Internal Medicine Journal, 43(11), 1171-1176.
Scopus5 WoS3 Europe PMC42013 Stewart, B., Turnbull, D., Mikocka-Walus, A., Harley, H., & Andrews, J. (2013). Acceptability of psychotherapy, pharmacotherapy, and self-directed therapies in Australians living with chronic hepatitis C. Journal of Clinical Psychology in Medical Settings, 20(4), 427-439.
Scopus3 WoS1 Europe PMC12013 Crocker, K., Chur-Hansen, A., & Andrews, J. (2013). Interpersonal relationships for patients with irritable bowel syndrome: A qualitative study of gps' perceptions. Australian Family Physician, 42(11), 805-810.
Scopus5 Europe PMC22013 McCallum, S., Mikocka-Walus, A., Keage, H., Churches, O., & Andrews, J. (2013). A novel treatment resource for co-occurring symptoms. Advances in Dual Diagnosis: policy, practice and research in mental health and substance use, 6(4), 155-167.
Scopus1 WoS12013 Selinger, C., Andrews, J., Dent, O., Norton, I., Jones, B., McDonald, C., . . . Leong, R. (2013). Cause-specific mortality and 30-year relative survival of Crohn's disease and ulcerative colitis. Inflammatory Bowel Diseases, 19(9), 1880-1888.
Scopus43 WoS47 Europe PMC252013 Hughes, P., Harrington, A., Castro Kraftchenko, J., Liebregts, T., Adam, B., Grasby, D., . . . Brierley, S. (2013). Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes. Gut, 62(10), 1456-1465.
Scopus170 WoS148 Europe PMC1182013 Andrews, J. (2013). Systematic review: IBD-associated pyoderma gangrenosum in the biologic era, the response to therapy. Alimentary Pharmacology & Therapeutics, 38(6), 563-572.
Scopus66 WoS49 Europe PMC472013 Mikocka-Walus, A., Gordon, A., Stewart, B., & Andrews, J. (2013). 'Just to get it off my chest': patients' views on psychotherapy in inflammatory bowel disease. Counselling and Psychotherapy Research; linking research with practice, 13(3), 227-234.
Scopus6 WoS42013 Ahl, A., Mikocka-Walus, A., Gordon, A., & Andrews, J. (2013). Are self-administered or minimal therapist contact psychotherapies an effective treatment for irritable bowel syndrome (IBS): A systematic review. Journal of Psychosomatic Research, 75(2), 113-120.
Scopus17 WoS14 Europe PMC122013 Lim, A., Grafton, R., Hetzel, D., & Andrews, J. (2013). Clinical audit: recent practice in caring for patients with acute severe colitis compared with published guidelines - is there a problem?. Internal Medicine Journal, 43(7), 803-809.
Scopus4 WoS3 Europe PMC22013 Hughes, P., Zola, H., Penttila, I., Blackshaw, L., Andrews, J., & Krumbiegel, D. (2013). Immune activation in irritable bowel syndrome: can neuroimmune interactions explain symptoms?. American Journal of Gastroenterology, 108(7), 1066-1074.
Scopus128 WoS109 Europe PMC892013 Zschau, N., Andrews, J., Holloway, R., Schoeman, M., Lange, K., Tam, W., & Holtmann, G. (2013). Gastroesophageal reflux disease after diagnostic endoscopy in the clinical setting. World Journal of Gastroenterology, 19(16), 2514-2520.
Scopus6 WoS6 Europe PMC52013 Mikocka-Walus, A., Andrews, J., von Kanel, R., & Moser, G. (2013). What are the implications of changing treatment delivery models for patients with inflammatory bowel disease: a discussion paper. European Journal of Gastroenterology & Hepatology, 25(4), 393-398.
Scopus15 WoS14 Europe PMC102013 Doecke, J., Simms, L., Zhao, Z., Huang, N., Hanigan, K., Krishnaprasad, K., . . . Radford-Smith, G. (2013). Genetic susceptibility in IBD: Overlap between ulcerative colitis and Crohn's disease. Inflammatory Bowel Diseases, 19(2), 240-245.
Scopus35 WoS30 Europe PMC262013 Mikocka-Walus, A., Andrews, J., von Kanel, R., & Moser, G. (2013). An improved model of care for inflammatory bowel disease (IBD). Journal of Crohn's and Colitis, 7(3), 120-121.
Scopus7 Europe PMC52013 Kennedy, N., Asser, T., Mountifield, R., Doogue, M., Andrews, J., & Bampton, P. (2013). Thiopurine metabolite measurement leads to changes in management of inflammatory bowel disease. Internal Medicine Journal, 43(3), 278-286.
Scopus23 WoS25 Europe PMC182013 Selinger, C. P., Leong, R. W. L., & Andrews, J. M. (2013). Cancer surveillance for patients with colonic Crohn's disease: Will your patients benefit?. Journal of Crohn's and Colitis, 7(12), e714.
2013 Andrews, J. M. (2013). Commentary: IBD combination therapy - Adalimumab plus immunosuppressants. Alimentary Pharmacology and Therapeutics, 37(1), 156.
2013 Fazal, M. W., Doogue, M. P., Leong, R. W., Bampton, P. A., & Andrews, J. M. (2013). Allopurinol use in pregnancy in three women with inflammatory bowel disease: Safety and outcomes: A case series. BMC Gastroenterology, 13(1), 5 pages.
Scopus11 WoS9 Europe PMC52013 Andrews, J. M. (2013). Commentary: Predicting relapse in Crohn's disease patients in remission with biologics. Alimentary Pharmacology and Therapeutics, 37(4), 497-498.
Scopus2 Europe PMC22012 Phan, V. -A. H., van Langenberg, D. R., Grafton, R., & Andrews, J. M. (2012). A dedicated inflammatory bowel disease service quantitatively and qualitatively improves outcomes in less than 18 months: a prospective cohort study in a large metropolitan centre. FRONTLINE GASTROENTEROLOGY, 3(3), 137-142.
WoS19 Europe PMC112012 Mikocka-Walus, A., Moulds, L., Rollbusch, N., & Andrews, J. (2012). "It's a tube up your bottom; it makes people nervous": the experience of anxiety in initial colonoscopy patients. Gastroenterology Nursing, 35(6), 392-401.
Scopus27 WoS21 Europe PMC102012 Stewart, B., Mikocka-Walus, A., Morgan, J., Colman, A., Phelps, M., Harley, H., & Andrews, J. (2012). Anxiety and depression in Australian chronic hepatitis C outpatients: prevalence and predictors. Australasian Psychiatry, 20(6), 496-500.
Scopus15 WoS13 Europe PMC112012 Jostins, L., & Andrews, J. (2012). Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature, 491(7422), 119-124.
Scopus3719 WoS3317 Europe PMC28812012 Mikocka-Walus, A., Andrews, J., Bernstein, C., Graff, L., Walker, J., Spinelli, A., . . . Moser, G. (2012). Integrated models of care in managing inflammatory bowel disease: a discussion. Inflammatory Bowel Diseases, 18(8), 1582-1587.
Scopus59 WoS46 Europe PMC372012 Van Langenberg, D., & Andrews, J. (2012). Satisfaction with patient-doctor relationships in inflammatory bowel diseases: examining patient-initiated change of specialist. World Journal of Gastroenterology, 18(18), 2212-2218.
Scopus13 WoS11 Europe PMC102012 Gapasin, J., Van Langenberg, D., Holtmann, G., Hetzel, D., & Andrews, J. (2012). Potentially avoidable surgery in inflammatory bowel disease: what proportion of patients come to resection without optimal preoperative therapy? A guidelines-based audit. Internal Medicine Journal, 42(5), e84-e88.
Scopus5 WoS5 Europe PMC52012 Tan, M., Holloway, R., Lange, K., & Andrews, J. (2012). General Practitioners' Knowledge of, and Attitudes to, Inflammatory Bowel Disease (IBD). Internal Medicine Journal (online), 42(7), 801-807.
Scopus39 WoS32 Europe PMC292012 Stewart, B., Mikocka-Walus, A., Harley, H., & Andrews, J. (2012). Help-seeking and coping with the psychosocial burden of chronic Hepatitis C: a qualitative study of patient, hepatologist, and counsellor perspectives. International Journal of Nursing Studies, 49(5), 560-569.
Scopus40 WoS34 Europe PMC342012 Mikocka-Walus, A., Turnbull, D., Holtmann, G., & Andrews, J. (2012). An integrated model of care for inflammatory bowel disease sufferers in Australia: Development and the effects of its implementation. Inflammatory Bowel Diseases, 18(8), 1573-1581.
Scopus39 WoS36 Europe PMC262012 Krishnaprasad, K., Andrews, J., Lawrance, I., Florin, T., Gearry, R., Leong, R., . . . Radford-Smith, G. (2012). Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study. Journal of Crohn's and Colitis, 6(3), 287-293.
Scopus13 WoS12 Europe PMC82012 Holtmann, G., & Andrews, J. (2012). A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease. Journal of Crohn's and Colitis, 6(3), 302-310.
Scopus89 WoS84 Europe PMC622012 Mikocka-Walus, A., Gordon, A., Stewart, B., & Andrews, J. (2012). The role of antidepressants in the management of inflammatory bowel disease (IBD): A short report on a clinical case-note audit. Journal of Psychosomatic Research, 72(2), 165-167.
Scopus35 WoS34 Europe PMC232012 Mikocka-Walus, A., Gordon, A., Stewart, B., & Andrews, J. (2012). A magic pill? A qualitative analysis of patients' views on the role of antidepressant therapy in inflammatory bowel disease (IBD). BMC Gastroenterology, 12(1), 1-9.
Scopus28 WoS21 Europe PMC162012 Andrews, J. M., & Tan, M. (2012). Probiotics in luminal gastroenterology: the current state of play. Internal Medicine Journal, 42(12), 1287-1291.
Scopus23 WoS17 Europe PMC112012 Mikocka-Walus, A., Moulds, L., Rollbusch, N., & Andrews, J. (2012). Why do colonoscopy patients reject research?. Journal of Psychosomatic Research, 72(4), 249-250.
Scopus1 WoS12011 Bryant, R., Van Langenberg, D., Holtmann, G., & Andrews, J. (2011). Functional gastrointestinal disorders in inflammatory bowel disease: Impact on quality of life and psychological status. Journal of Gastroenterology and Hepatology, 26(5), 916-923.
Scopus75 WoS63 Europe PMC532011 Besanko, L., Burgstad, C., Mountifield, R., Andrews, J., Heddle, R., Checklin, H., & Fraser, R. (2011). Lower esophageal sphincter relaxation is impaired in older patients with dysphagia. World Journal of Gastroenterology, 17(10), 1326-1331.
Scopus23 WoS17 Europe PMC152011 Andrews, J. (2011). Le plus ca change: Why we need better biomarkers to predict outcomes in ulcerative colitis. Journal of Gastroenterology and Hepatology, 26(7), 1085-1086.
Scopus3 WoS12011 Haag, S., Andrews, J., Gapasin, J., Gerken, G., Keller, A., & Holtmann, G. (2011). A 13-nation population survey of upper gastrointestinal symptoms: Prevalence of symptoms and socioeconomic factors. Alimentary Pharmacology & Therapeutics, 33(6), 722-729.
Scopus32 WoS25 Europe PMC162011 Andrews, J., & Holtmann, G. (2011). Stress causes flares of IBD: how much evidence is enough?. Nature Reviews Gastroenterology and Hepatology, 8(1), 13-14.
Scopus10 WoS9 Europe PMC92010 Mountifield, R., Prosser, R., Bampton, P., Muller, K., & Andrews, J. (2010). Pregnancy and IBD treatment: This challenging interplay from a patients' perspective. Journal of Crohn's and Colitis, 4(2), 176-182.
Scopus65 WoS57 Europe PMC452010 Andrews, J., Mountifield, R., Van Langenberg, D., Bampton, P., & Holtmann, G. (2010). Un-promoted Issues in Inflammatory Bowel Disease (IBD): Opportunities to Optimise Care. Internal Medicine Journal, 40(3), 173-182.
Scopus44 WoS41 Europe PMC332010 Andrews, J., Bryant, R., Van Langenberg, D., & Holtmann, G. (2010). Are all symptoms in patients in IBD due to occult inflammation. American Journal of Gastroenterology, 105(12), 2703.
Scopus3 WoS22010 Lawrance, I., Radford-Smith, G., Bampton, P., Andrews, J., Tan, P., Croft, A., . . . Florin, T. (2010). Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: An Australian and New Zealand experience. Journal of Gastroenterology and Hepatology, 25(11), 1732-1738.
Scopus79 WoS69 Europe PMC562010 Van Langenberg, D., Lange, K., Hetzel, D., Holtmann, G., & Andrews, J. (2010). Adverse clinical phenotype in inflammatory bowel disease: A cross sectional study identifying factors potentially amenable to change. Journal of Gastroenterology and Hepatology, 25(7), 1250-1258.
Scopus33 WoS30 Europe PMC272010 Muller, K., Prosser, R., Bampton, P., Mountifield, R., & Andrews, J. (2010). Female gender and surgery impair relationships, body image, and sexuality in inflammatory bowel disease: patient perceptions. Inflammatory Bowel Diseases, 16(4), 657-663.
Scopus148 WoS120 Europe PMC942010 Connell, W., Andrews, J., & Sparrow, M. (2010). Practical guidelines for treating inflammatory bowel disease safely with anti-tumour necrosis factor therapy in Australia. Internal Medicine Journal, 40(2), 139-149.
Scopus12 WoS11 Europe PMC72010 Van Langenberg, D., Simon, S., Holtmann, G., & Andrews, J. (2010). The burden of inpatient costs in inflammatory bowel disease and opportunities to optimize care: A single metropolitan Australian center experience. Journal of Crohn's and Colitis, 4(4), 413-421.
Scopus27 WoS27 Europe PMC232010 Mikocka-Walus, A., & Andrews, J. M. (2010). Establishing a biopsychosocial model of care for gastroenterology outpatients: A South Australian experience. JOURNAL OF PSYCHOSOMATIC RESEARCH, 68(6), 649. 2010 Mountifield, R., & Andrews, J. M. (2010). Managing irritable bowel syndrome. Medicine Today, 11(2), 32-40.
Scopus22010 Andrews, J. M., Oster, C., Grafton, R., Hetzel, D. J., & Lawrence, M. (2010). A necessary evil: patients' experiences of and attitudes to surgical care for Inflammatory Bowel Disease (IBD). JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 25, A87. 2010 Kennedy, N. A., Doogue, M., Andrews, J. M., & Bampton, P. A. (2010). How thiopurine metabolite measurements affect management of inflammatory bowel disease, South Australia: the first 18 months. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 25, A99. 2009 Haag, S., Andrews, J., Gapasin, J., Keller, A., & Holtmann, G. (2009). Eine 13-Länderstudie zu Oberbauchbeschwerden: Die Bedeutung von Alter und Geschlecht. Zeitschrift für Gastroenterologie, 47(09).
2009 Van Langenberg, D. R., & Andrews, J. M. (2009). Do IBD patients change specialists? if so, does it matter?. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 24, A225-A226. 2009 Haag, S., Andrews, J., Katelaris, P., Gapasin, J., Galmiche, J., Hunt, R., . . . Holtmann, G. (2009). Management of reflux symptoms with over-the-counter proton pump inhibitors: Issues and proposed guidelines. Digestion, 80(4), 226-234.
Scopus32 WoS23 Europe PMC162009 Mikocka-Walus, A., Turnbull, D., Andrews, J., Moulding, N., Wilson, I., & Holtmann, G. (2009). Does doctors' knowledge of inflammatory bowel disease patients' psychological status affect patients' clinical outcomes: a pilot randomized controlled trial. European Journal of Gastroenterology & Hepatology, 21(4), 394-395.
Scopus3 Europe PMC42009 Mikocka-Walus, A., Turnbull, D., Andrews, J., Moulding, N., Wilson, I., & Holtmann, G. (2009). Psychogastroenterology: a call for psychological input in Australian gastroenterology clinics. Internal Medicine Journal, 39(2), 127-130.
Scopus16 WoS14 Europe PMC122009 Andrews, J., Travis, S., Gibson, P., & Gasche, C. (2009). Systematic review: does concurrent therapy with 5-ASA and immunomodulators in inflammatory bowel disease improve outcomes?. Alimentary Pharmacology & Therapeutics, 29(5), 459-469.
Scopus53 WoS44 Europe PMC302009 Mountifield, R., Bampton, P., Prosser, R., Muller, K., & Andrews, J. (2009). Fear and fertility in inflammatory bowel disease; A mismatch of perception and reality affects family planning decisions. Inflammatory Bowel Diseases, 15(5), 720-725.
Scopus205 WoS169 Europe PMC1302009 Collins, J., Farrall, E., Turnbull, D., Hetzel, D., Holtmann, G., & Andrews, J. (2009). Do we know what patients want? The doctor-patient communication gap in functional gastrointestinal disorders. Clinical Gastroenterology and Hepatology, 7(11), 1252-1254.
Scopus37 WoS31 Europe PMC202009 Andrews, J., Heddle, R., Hebbard, G., Checklin, H., Besanko, L., & Fraser, R. (2009). Age and gender affect likely manometric diagnosis: Audit of a tertiary referral hospital clinical esophageal manometry service. Journal of Gastroenterology and Hepatology, 24(1), 125-128.
Scopus23 WoS16 Europe PMC112008 Mikocka-Walus, A., Turnbull, D., Moulding, N., Wilson, I., Andrews, J., & Holtmann, G. (2008). Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients. Journal of Gastroenterology and Hepatology, 23(7 Part 1), 1137-1143.
Scopus38 WoS36 Europe PMC262008 Mikocka-Walus, A., Turnbull, D., Moulding, N., Wilson, I., Holtmann, G., & Andrews, J. (2008). Does psychological status influence clinical outcomes in patients with inflammatory bowel disease (IBD) and other chronic gastroenterological diseases: An observational cohort prospective study. BioPsychoSocial Medicine, 2(11), 1-9.
Scopus49 WoS44 Europe PMC362008 Mikocka-Walus, A., Turnbull, D., Andrews, J., Moulding, N., Wilson, I., Harley, H., . . . Holtmann, G. (2008). Psychological problems in gastroenterology outpatients: A South Australian experience. Psychological co-morbidity in IBD, IBS and hepatitis C. Clinical Practice and Epidemiology in Mental Health, 4(1), 1-8.
Scopus57 Europe PMC262008 Andrews, J., Fraser, R., Heddle, R., Hebbard, G., & Checklin, H. (2008). Is esophageal dysphagia in the extreme elderly (≥80 years) different to dysphagia younger adults? A clinical motility service audit. Diseases of the Esophagus, 21(7), 656-659.
Scopus17 WoS16 Europe PMC102008 Mikocka-Walus, A., Turnbull, D., Andrews, J., Moulding, N., & Holtmann, G. (2008). The effect of functional gastrointestinal disorders on psychological comorbidity and quality of life in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics, 28(4), 475-483.
Scopus55 WoS55 Europe PMC412007 Mikocka-Walus, A., Turnbull, D., Moulding, N., Wilson, I., Andrews, J., & Holtmann, G. (2007). "It doesn't do any harm, but patients feel better": a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease. BMC Gastroenterology, 7(1), 38-43.
Scopus41 WoS36 Europe PMC282007 Mikocka-Walus, A., Turnbull, D., Moulding, N., Wilson, I., Andrews, J., & Holtmann, G. (2007). Controversies surrounding the comorbidity of depression and anxiety in inflammatory bowel disease patients: A literature review. Inflammatory Bowel Diseases, 13(2), 225-234.
Scopus150 WoS124 Europe PMC1022006 Mikocka-Walus, A., Turnbull, D., Moulding, N., Wilson, I., Andrews, J., & Holtmann, G. (2006). Antidepressants and inflammatory bowel disease: a systematic review. Clinical Practice and Epidemiology in Mental Health, 2(24), 1-9.
Scopus106 Europe PMC652006 Andrews, J. M. (2006). Letter: "Positive" family planning: Another personal viewpoint. Medical Journal of Australia, 184(12), 645-646. 2006 Andrews, J. M. (2006). "Positive" family planning: Another personal viewpoint [3]. Medical Journal of Australia, 184(12), 645-646.
2003 Andrews, J. M. (2003). Letter to the editor [2]. Neurogastroenterology and Motility, 15(3), 335.
2003 Feinle-Bisset, C., O'Donovan, D., Doran, S., Andrews, J., Wishart, J., Chapman, I., & Horowitz, M. (2003). Effects of fat digestion on appetite, APD motility, and gut hormones in response to duodenal fat infusion in humans. American Journal of Physiology-Gastrointestinal and Liver Physiology, 284(5), G798-G807.
Scopus167 WoS157 Europe PMC1102003 Feinle-Bisset, C., & Andrews, J. (2003). Treatment of functional dyspepsia. Current Treatment Options in Gastroenterology, 6(4), 289-297.
Europe PMC72002 Andrews, J., O'Donovan, D., Hebbard, G., Malbert, C., Doran, S., & Dent, J. (2002). Human duodenal phase III migrating motor complex activity is predominantly antegrade, as revealed by high-resolution manometry and colour pressure plots. Neurogastroenterology and Motility, 14(4), 331-338.
Scopus25 WoS19 Europe PMC132002 Andrews, J. (2002). Hiatus hernia: What the GP needs to know. Medicine Today, 3(1), 39-43. 2001 Andrews, J., Doran, S., Di Matteo, A., Leong, L., MacIntosh, C., Chiu, C., . . . Fraser, R. (2001). Effect of a lacto-ovo vegetarian diet on fasting small intestinal motility. Scandinavian Journal of Gastroenterology, 36(10), 1037-1043.
Scopus2 WoS1 Europe PMC12001 Andrews, J., Doran, S., Hebbard, G., Malbert, C., Horowitz, M., & Dent, J. (2001). Nutrient-induced spatial patterning of human duodenal motor function. American Journal of Physiology-Gastrointestinal and Liver Physiology, 280(3), G501-G509.
Scopus41 WoS33 Europe PMC161999 Andrews, J., Nathan, H., Malbert, C. H., Verhagen, M., Gabb, M., Hebbard, G., . . . Dent, J. (1999). Validation of a novel luminal flow velocimeter with video fluoroscopy and manometry in the human esophagus. The American journal of physiology, 276(4), G886-G894.
Scopus1 WoS11999 Verhagen, M. A. M. T., Rayner, C. K., Andrews, J. M., Hebbard, G. S., Doran, S. M., Samsom, M., & Horowitz, M. (1999). Physiological changes in blood glucose do not affect gastric compliance and perception in normal subjects. American Journal of Physiology - Gastrointestinal and Liver Physiology, 276(3 39-3), G761-G766.
Scopus28 WoS26 Europe PMC121999 MacIntosh, C., Andrews, J., Jones, K., Wishart, J., Morris, H., Jansen, J., . . . Chapman, I. (1999). Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility. American Journal of Clinical Nutrition, 69(5), 999-1006.
Scopus209 WoS187 Europe PMC1351998 Andrews, J. M., Doran, S., Hebbard, G. S., Rassias, G., Sun, W. M., & Horowitz, M. (1998). Effect of glucose supplementation on appetite and the pyloric motor response to intraduodenal glucose and lipid. American Journal of Physiology - Gastrointestinal and Liver Physiology, 274(4 37-4), G645-G652.
Scopus30 WoS27 Europe PMC121998 Andrews, J., Rayner, C., Doran, S., Hebbard, G., & Horowitz, M. (1998). Physiological changes in blood glucose affect appetite and pyloric motility during intraduodenal lipid infusion. American Journal of Physiology. Gastrointestinal and Liver Physiology, 275(4), G797-G804.
Scopus40 WoS39 Europe PMC181998 Doran, S., Jones, K., Andrews, J., & Horowitz, M. (1998). Effects of meal volume and posture on gastric emptying of solids and appetite. American Journal of Physiology. Regulatory Integrative and Comparative Physiology, 275(5), R1712-R1718.
Scopus77 WoS65 Europe PMC361998 Andrews, J., Doran, S., Hebbard, G., Rassias, G., Sun, W. M., & Horowitz, M. (1998). The effect of dietary supplementation with glucose on appetite and antropyloroduodenal motility. American Journal of Physiology, 274, G645-G652. 1998 Lavin, J., Wittert, G., Andrews, J., Yeap, B., Wishart, J., Morris, H., . . . Read, N. (1998). Interaction of insulin, glucagon-like peptide 1, gastric inhibitory polypeptide, and appetite in response to intraduodenal carbohydrate1–3. American Journal of Clinical Nutrition, 68(3), 591-598.
Scopus112 WoS94 Europe PMC651997 Cook, C., Andrews, J., Jones, K., Wittert, G., Chapman, I., Morley, J., & Horowitz, M. (1997). The effects of small intestinal nutrient infusion on appetite and pyloric motility are modified by age. American Journal of Physiology. Regulatory Integrative and Comparative Physiology, 273(2), R755-R761.
WoS1061997 Smithson, J., Campbell, A., Andrews, J., Milton, J., Pigott, R., & Jewell, D. (1997). Altered expression of mucins throughout the colon in ulcerative colitis.. Gut, 40(2), 234-240.
Scopus361997 Russo, A., Sun, W. M., Sattawatthamrong, Y., Fraser, R., Horowitz, M., Boeckxstaens, G., . . . Read, N. (1997). Acute hyperglycaemia affects anorectal motor and sensory function in normal subjects. Gut, 41(4), 494-499.
Scopus44 WoS39 Europe PMC231997 Hebbard, G., Samsom, M., Andrews, J., Carman, D., Tansell, B., Sun, W. M., . . . Horowitz, M. (1997). Hyperglycaemia affects gastric electrical rhythm and nausea during intraduodenal triglyceride infusion.. Digestive Diseases and Sciences, 42(3), 568-575.
Scopus34 WoS29 Europe PMC171996 Andrews, J., & Horowitz, M. (1996). Gastric function in the elderly. Clinical Geriatrics, 4, 21-43. 1995 Andrews, J., Norton, I., Dent, O., & Goulston, K. (1995). Inflammatory bowel disease: A retrospective review of a specialist based cohort. Medical Journal of Australia, 163(3), 133-136.
Scopus16 Europe PMC101994 Andrews, J., & Goulston, K. (1994). Inflammatory bowel disease - Its history, current status and outlook. Medical Journal of Australia, 160(4), 219-223.
Scopus10 Europe PMC51993 Andrews, J. (1993). Gastric mucosal phospholipids and gastroduodenal diseases. Gut, 34(12), 1741-1742.
1990 Rush, D., Andrews, J., Kristal, A., Kristal, A., & Kristal, A. (1990). Maternal Cigarette Smoking During Pregnancy, Adiposity, Social Class, and Perinatal Outcome in Cardiff, Wales, 1965-1977. American Journal of Perinatology, 7(4), 319-326.
Scopus9 Europe PMC41983 Jones, B. J. M., Lees, R., Andrews, J., Frost, P., & Silk, D. B. (1983). Comparison of an elemental and polymeric enteral diet in patients with normal gastrointestinal function. Gut, 24(1), 78-84.
Scopus109 Europe PMC72- Liu, W., Mäkinen, V. -P., Tilley, W. D., & Pederson, S. M. (n.d.). sSNAPPY: an R/Bioconductor package for single-sample directional pathway perturbation analysis. F1000Research, 13, 628.
-
Books
-
Book Chapters
Year Citation 2019 Duong, T., & Andrews, J. M. (2019). Common gastrointestinal investigations and psychological concerns. In Psychogastroenterology for Adults: A Handbook for Mental Health Professionals (pp. 105-118). Routledge.
DOI2018 Linedale, E., Mikocka-Walus, A., & Andrews, J. (2018). Future challenges and directions in functional gastrointestinal disorders - integrated biopsychosocial care approaches. In S. Knowles, J. Stern, & G. Hebbard (Eds.), Functional Gastrointestinal Disorders. A Biopsychosocial Approach (pp. 288-296). New York, NY: Routledge. 2015 Andrews, J. (2015). IBD: What is it and does psyche have anything to do with it?. In S. Knowles, & A. Mikocka-Walus (Eds.), Psychological Aspects of Inflammatory Bowel Disease: A Biopsychosocial Approach (pp. 1-9). Hove, East Sussex: Routledge.
DOI Scopus12010 Blackshaw, L., & Andrews, J. (2010). Small intestinal motor and sensory function and dysfunction. In Sleisenger and Fortran's Gastrointestinal and Liver Disease: Pathology, Diagnosis, Management (9 ed., pp. 1643-1659). United States: Elsevier Saunders.
Scopus22006 Mikocka-Walus, A., Turnbull, D., Moulding, N., Andrews, J., & Holtmann, G. (2006). Do antidepressants have an impact on the course of inflammatory bowel disease: South Australian gatroenterologists' perspectives. In D. M. Katsikitis (Ed.), Unknown Book (pp. 259-263). Level 11, 257 Collins Street, Melbourne VIC: AUSTPSYCHSOC. -
Conference Papers
Year Citation 2024 Goodsall, T. M., Day, A. S., Andrews, J. M., Ruszkiewicz, A., Ma, C., & Bryant, R. V. (2024). Composite Assessment Using Intestinal Ultrasound and Calprotectin Is Accurate in Predicting Histological Activity in Ulcerative Colitis: A Cohort Study. In Inflammatory Bowel Diseases Vol. 30 (pp. 190-195). England: OXFORD UNIV PRESS INC.
DOI Scopus9 WoS4 Europe PMC32022 Lores, T., Andrews, J. M., Evans, S., Chur-Hansen, A., Goess, C., Smith, L., . . . Mikocka-Walus, A. (2022). A randomized controlled pilot trial of virtual adjunctive gut-directed hypnotherapy for people with Crohn's disease. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 130-131). WILEY. 2022 Danese, S., Panaccione, R., Rubin, D. T., Sands, B. E., Reinisch, W., D'Haens, G., . . . Feagan, B. G. (2022). Clinical efficacy and safety of guselkumab maintenance therapy in patients with moderately to severely active Crohn's disease: Week 48 analyses from the Phase 2 GALAXI-1 study. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 127-129). WILEY. 2022 Danese, S., Panaccione, R., Rubin, D. T., Sands, B. E., Reinisch, W., D'Haens, G., . . . Feagan, B. (2022). Clinical efficacy and safety of guselkumab maintenance therapy in patients with moderately to severely active Crohn's Disease: Week 48 analyses from the phase 2 GALAXI 1 study. In JOURNAL OF CROHNS & COLITIS Vol. 16 (pp. I026-I027). OXFORD UNIV PRESS.
WoS72022 Andrews, J. M., D'Haens, G., Kobayashi, T., Morris, N., Lissoos, T., Hoover, A., . . . Sands, B. E. (2022). Efficacy and safety of mirikizumab as induction therapy in patients with moderately to severely active ulcerative colitis: Results from the Phase 3 LUCENT-1 study. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 132-133). WILEY. 2022 An, Y. -K., Lindsay, N., Allan, N., Khoo, E., Amiss, A., Moniruzzaman, M., . . . Begun, J. (2022). Post-induction IL-12/23 levels correlate with clinical response and remission after ustekinumab in a multicenter prospective cohort study of patients with Crohn's disease: Preliminary induction results of the AURORA study, including the Australia New Zealand IBD Consortium Cohort. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 146-147). WILEY. 2022 Barnes, A., Carter, D., Kaazan, P., Walsh, A., Connor, S., & Andrews, J. M. (2022). Novel inflammatory bowel disease (IBD) specific electronic medical record allows scalable auditing of IBD severity, therapy and complications to show the current unmet need in IBD care. In Intestinal Research Vol. 20 (pp. 506-508). Korea (South): KOREAN ASSOC STUDY INTESTINAL DISEASES.
DOI2022 Danese, S., Panaccione, R., Rubin, D. T., Sands, B. E., Reinisch, W., D'Haens, G., . . . Feagan, B. G. (2022). Clinical Efficacy and Safety of Guselkumab Maintenance Therapy in Patients with Moderately to Severely Active Crohn's Disease: Week 48 Analyses from the Phase 2 GALAXI 1 Study. In ARTHRITIS & RHEUMATOLOGY Vol. 74 (pp. 3656-3660). PA, Philadelphia: WILEY. 2022 Begun, J., Andrews, J., Chuang, E., Rahimian, P., Smith, J. A., & Singh, S. (2022). Pilot Study to Assess Pharmacokinetic and Pharmacodynamic Markers Following Enema-Dosing With Adalimumab in Patients With Active Ulcerative Colitis (UC). In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 117 (pp. S574). LIPPINCOTT WILLIAMS & WILKINS. 2022 Afzali, A., Panes, J., Rubin, D. T., Sands, B. E., Reinisch, W., D'Haens, G., . . . Terry, N. (2022). Efficacy Outcomes by Symptom-Based Response Status After Induction: Week-48 Results from the GALAXI 1 Trial of Guselkumab in Crohn's Disease. In AMERICAN JOURNAL OF GASTROENTEROLOGY Vol. 117 (pp. S580). LIPPINCOTT WILLIAMS & WILKINS. 2021 Kaazan, P., Tan, Z., Maiyani, P., Mickenbecker, M., Edwards, S., Mcivor, C., & Andrews, J. (2021). Weight and body mass index patterns in a cohort of patients with inflammatory bowel disease treated with biological agents. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 36 (pp. 105-106). WILEY. 2021 Barnes, A., Spizzo, P., Mountifield, R., Bampton, P., Andrews, J., Fraser, R. J., & Mukherjee, S. (2021). Sleep quality in patients with inflammatory bowel disease: A systematic review and meta-analysis. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 36 (pp. 101). WILEY. 2021 Pipicella, J. L., Vernon-Roberts, A., Walsh, A., Wierzbicki, A., Day, A. S., Carter, D. W., . . . Andrews, J. M. (2021). Using a consensus-based method to develop a novel pediatric-specific inflammatory bowel disease eHealth clinical management system. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 36 (pp. 165-166). WILEY. 2021 Duong, T. A., Bryant, R., Andrews, J., & Lynch, K. (2021). High reported willingness to have COVID-19 vaccination among Australian patients with inflammatory bowel disease. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 36 (pp. 127). WILEY. 2021 Abeyratne, K., Harb, M., Bensted, K., Ghaly, S., Connor, S., Andrews, J., & Lynch, K. (2021). Validity of stomal calprotectin measurement in assessing Crohn's disease activity. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 36 (pp. 125). WILEY. 2021 Kaazan, P., Tan, Z., Maiyani, P., Mickenbecker, M., Edwards, S., McIvor, C., & Andrews, J. M. (2021). Weight patterns in biologicals treated Inflammatory bowel disease cohort. In JOURNAL OF CROHNS & COLITIS Vol. 15 (pp. S385-S386). OXFORD UNIV PRESS.
DOI2021 Day, A., Yao, C. K., Costello, S., Andrews, J., & Bryant, R. (2021). Food-related quality of life in adults with Inflammatory Bowel Disease is influenced by restrictive eating behaviour, disease activity and surgery: a prospective multi-centre study. In JOURNAL OF CROHNS & COLITIS Vol. 15 (pp. S368). OXFORD UNIV PRESS.
DOI2021 Danese, S., Sandborn, W. J., Feagan, B. G., Weisel, K., Gonzalez, S., Frustaci, M. E., . . . Panes, J. (2021). The effect of guselkumab induction therapy on early clinical outcome measures in patients with Moderately to Severely Active Crohn's Disease: Results from the phase 2 GALAXI 1 study. In JOURNAL OF CROHNS & COLITIS Vol. 15 (pp. S027-S028). OXFORD UNIV PRESS.
DOI WoS42020 Tan, Z., Kaazan, P., Maiyani, P., Bednarz, J., Mcivor, C., & Andrews, J. M. (2020). Group-based trajectory analysis of weight change in an infliximab-treated cohort of patients with inflammatory bowel disease. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 35 (pp. 127). WILEY. 2020 Day, A., Yao, C. K., Costello, S., Ruszkiewicz, A., Andrews, J., Gibson, P., & Bryant, R. (2020). Evaluation of the tolerance and effect on disease activity of a new dietary strategy (4-SURE diet) for mild-moderately active ulcerative colitis. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 35 (pp. 191-192). WILEY.
WoS12020 Barnes, A., Spizzo, P., Andrews, J., & Mountifield, R. (2020). Medication non-adherence among patients with inflammatory bowel disease during the COVID-19 pandemic is associated with increased disease activity and corticosteroid usage. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 35 (pp. 135). WILEY. 2019 Kaazan, P., Krishnaprasad, K., Mountifield, R., & Andrews, J. (2019). Disease-specific electronic medical records in chronic disease: Is the emerging inflammatory bowel disease experience a possible solution?. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 34 (pp. 127-128). WILEY. 2019 Kaazan, P., Tan, Z., Hughes, J., Grafton, R., & Andrews, J. (2019). Infliximab-related weight gain in patients with inflammatory bowel disease: Patterns, associations, and financial impacts. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 34 (pp. 138-139). WILEY. 2019 Lim, E., Thai, M., Hendy, P., Alchlaihawi, M., Leong, R., Connor, S., . . . Begun, J. (2019). Endoscopic balloon dilatation is safe and has a high success rate in patients with stricturing Crohn's disease. In JOURNAL OF CROHNS & COLITIS Vol. 13 (pp. S374). OXFORD UNIV PRESS.
DOI2018 Lores, T. J., Goess, C., Grafton, R., Hughes, J. C., Cronin, L., Burke, A., . . . Andrews, J. M. (2018). Psychological care is needed and welcomed by patients with inflammatory bowel disease under routine care. In GASTROENTEROLOGY Vol. 154 (pp. S806). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. 2017 Lores, T., Goess, C., Hrycek, C., Grafton, R., Hughes, J., Cronin, L., . . . Andrews, J. M. (2017). P170 Integrated psychological care in outpatients with inflammatory bowel disease. In Journal of Crohn's and Colitis Vol. 11 (pp. S163). Oxford University Press (OUP).
DOI2015 Linedale, E. C., Mikocka-Walus, A., Gibson, P. G., & Andrews, J. M. (2015). Could a structured screening approach be the answer to the avalanche of functional gastrointestinal disorder referrals?. In Journal of Gastroenterology and Hepatology Vol. 30 (pp. 20). Brisbane, Queensland, Australia. 2015 Ooi, S. -Y. J., Gounder, M., Grafton, R., Leach, P., Bampton, P. A., Sechi, A., . . . Andrews, J. M. (2015). Thiopurine Metabolite Testing to Guide Management in Inflammatory Bowel Disease (IBD) Yields Clinical Benefit At 12 Months: A Retrospective Observational Study. In GASTROENTEROLOGY Vol. 148 (pp. S861). Washington, DC: W B SAUNDERS CO-ELSEVIER INC.
WoS12015 Wright, E. K., Kamm, M. A., Selvaraj, F., Princen, F., De Cruz, P., Hamilton, A. L., . . . Singh, S. (2015). Preventing Crohn's Disease Recurrence After Resection With Adalimumab: Role of Drug and Anti-Drug Antibody Levels. In GASTROENTEROLOGY Vol. 148 (pp. S849). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. 2015 Hamilton, A. L., Kamm, M. A., Selvaraj, F., Princen, F., De Cruz, P., Wright, E. K., . . . Singh, S. (2015). Need for Recurrent Resection and Complex Phenotype Are Associated With a Specific Antibody Signature in Crohn's Disease Patients Undergoing Resection; Smoking Is Not Associated With Prevalent Antibodies; Prognostic and Mechanistic Implications. In GASTROENTEROLOGY Vol. 148 (pp. S238-S239). Washington, DC: W B SAUNDERS CO-ELSEVIER INC. 2015 Hamilton, A. L., Kamm, M. A., Selvaraj, F., Princen, F., De Cruz, P., Wright, E. K., . . . Singh, S. (2015). Serological Antibodies for the Prediction of Post-Operative Recurrent Crohn's Disease Results From the POCER Study. In GASTROENTEROLOGY Vol. 148 (pp. S116). Washington, DC: W B SAUNDERS CO-ELSEVIER INC.
WoS22014 Wright, E. K., De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, S., . . . Desmond, P. V. (2014). Intestinal Resection in Crohn's Disease Is Associated With Significant and Durable Improvement in Health Related Quality of Life Although to a Lesser Extent in Women and Smokers. Results From the POCER Study. In GASTROENTEROLOGY Vol. 146 (pp. S435). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC.
WoS22014 Bennett, A., Moore, D., Bampton, P. A., & Andrews, J. M. (2014). What Happens to Patients With Paediatric Onset Inflammatory Bowel Disease (IBD) After Transition to Adult Care and What Is Their View of the Process?. In GASTROENTEROLOGY Vol. 146 (pp. S373-S374). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. 2014 Bennett, A., Wichmann, M., Andrews, J. M., & Bampton, P. A. (2014). Rural and Remote Care for Patients With Inflammatory Bowel Disease - Perceived Barriers Despite Good Non-Expert Practitioner Knowledge. In GASTROENTEROLOGY Vol. 146 (pp. S373). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. 2014 Wright, E. K., De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, S., . . . Desmond, P. V. (2014). Faecal Calprotectin Is Superior to Faecal Lactoferrin and S100A12 As a Surrogate Marker for Post-Operative Crohn's Disease Endoscopic Recurrence. Prospective Longitudinal Endoscopic Validation. Results From the POCER Study. In GASTROENTEROLOGY Vol. 146 (pp. S174). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC.
WoS12014 Heap, G. A., Singh, A., Bewshea, C. M., Weedon, M., Dubois, P., Andrews, J. M., . . . Ahmad, T. (2014). Thiopurine Induced Pancreatitis in Inflammatory Bowel Disease: Clinical Features and Genetic Determinants. In GASTROENTEROLOGY Vol. 146 (pp. S2). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. 2013 De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, S., Gorelik, A., . . . Desmond, P. (2013). Optimising post-operative Crohn's disease management: best drug therapy alone versus colonoscopic monitoring with treatment step-up. The POCER study. In GASTROENTEROLOGY Vol. 144 (pp. S164). Orlando, FL: W B SAUNDERS CO-ELSEVIER INC.
WoS142013 Wright, E. K., De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K., Krejany, S., . . . Desmond, P. V. (2013). Faecal calprotectin helps determine the need for post-operative colonoscopy in crohn's disease. prospective longitudinal endoscopic validation. Results from the POCER study. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 28 (pp. 106). WILEY-BLACKWELL.
WoS22013 Harrington, A. M., Castro, J., Young, R. L., Kurtz, C. B., Silos-Santiago, A., Nguyen, N. Q., . . . Brierley, S. M. (2013). Alterations in the Guanylate Cyclase-C/cGMP Pathway in Patients With Irritable Bowel Syndrome With Constipation. In GASTROENTEROLOGY Vol. 144 (pp. S59-S60). Orlando, FL: W B SAUNDERS CO-ELSEVIER INC. 2012 De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Gorelik, A., Liew, D., . . . Desmond, P. (2012). Clinical Risk Stratification Predicts Development of Endoscopic Recurrence After Crohn's Disease Surgery: Early Results From the POCER Study. In GASTROENTEROLOGY Vol. 142 (pp. S568). San Diego, CA: W B SAUNDERS CO-ELSEVIER INC.
WoS52012 Radford-Smith, G., Hartnell, F., Jones, L. V., Krishnaprasad, K., Prosser, R., Marr, D., . . . Gearry, R. B. (2012). Predicting Long-Term Response to Anti-TNF Therapy in Crohn's Disease. In GASTROENTEROLOGY Vol. 142 (pp. S360). San Diego, CA: W B SAUNDERS CO-ELSEVIER INC.
WoS12012 Radford-Smith, G., Krishnaprasad, K., Andrews, J. M., Bampton, P. A., Simms, L., Mahy, G., . . . Lawrance, I. C. (2012). Colectomy for Ulcerative Colitis Across Australia and New Zealand: Indications, Risk Factors and Rates - an ANZ IBD Consortium Study. In GASTROENTEROLOGY Vol. 142 (pp. S262). San Diego, CA: W B SAUNDERS CO-ELSEVIER INC. 2012 De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Gorelik, A., Liew, D., . . . Desmond, P. (2012). Adalimumab Prevents Post-Operative Crohn's Disease Recurrence, and is Superior to Thiopurines: Early Results From the POCER Study. In GASTROENTEROLOGY Vol. 142 (pp. S212). San Diego, CA: W B SAUNDERS CO-ELSEVIER INC.
WoS162010 Mikocka-Walus, A. A., Van Langenberg, D. R., Holtmann, G., & Andrews, J. M. (2010). Psychogastroenterology: A Biopsychosocial Approach to Treating Inflammatory Bowel Disease (IBD). In GASTROENTEROLOGY Vol. 138 (pp. S161). W B SAUNDERS CO-ELSEVIER INC. 2010 Mikocka-Walus, A. A., Bond, M., Holloway, R. H., Persson, J., Pilichiewicz, A. N., Hughes, P. A., . . . Andrews, J. M. (2010). Does Cognitive-Behavioural Therapy (CBT) Improve Outcomes in Inflammatory Bowel Disease (IBD)? Initial Feasibility Report on a Pilot Randomised Controlled Trial. In GASTROENTEROLOGY Vol. 138 (pp. S521-S522). W B SAUNDERS CO-ELSEVIER INC.
WoS52009 Lawrance, I. C., Bampton, P. A., Sparrow, M., Gearry, R. B., Leong, R. W., Andrews, J. M., . . . Florin, T. H. (2009). Serious Infective Complications in Anti-TNFα Treated Inflammatory Bowel Disease Patients. In GASTROENTEROLOGY Vol. 136 (pp. A189). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. 2009 Zschau, N. B., Holtmann, G., Holloway, R. H., Schoeman, M., Lange, K., Tam, W., & Andrews, J. M. (2009). Do Concomitant Functional Dyspepsia and Irritable Bowel Syndrome Influence Changes in Quality of Life in Patients with Gastroesophageal Reflux Symptoms Referred for Endoscopy? - the MAPSOMAL Study. In GASTROENTEROLOGY Vol. 136 (pp. A431). Chicago, IL: W B SAUNDERS CO-ELSEVIER INC. 2008 Muller, K. R., Prosser, R., Bampton, P. A., & Andrews, J. M. (2008). Female gender and surgery lead to greater perceived impact of inflammatory bowel disease (IBD) on body image and sexual function: a neglected issue. In GASTROENTEROLOGY Vol. 134 (pp. A140). San Diego, CA: W B SAUNDERS CO-ELSEVIER INC.
WoS22008 Mountifield, R. E., Prosser, R., Bampton, P. A., & Andrews, J. M. (2008). Fear and fertility in Inflammatory Bowel Disease - A mismatch of perception and reality affects patient behaviour. In GASTROENTEROLOGY Vol. 134 (pp. A641). W B SAUNDERS CO-ELSEVIER INC. 2008 Andrews, J. M., Mikocka-Walus, A. A., Turnbull, D. A., Hetzel, D. J., & Hohmann, G. J. (2008). Concomitant symptoms of functional gastrointestinal disorders (FGIDs) in patients with Inflammatory Bowel Disease (IBD) are associated with decreased quality of life (Qol). In GASTROENTEROLOGY Vol. 134 (pp. A499). W B SAUNDERS CO-ELSEVIER INC. 2008 Mikocka-Walus, A. A., Andrews, J. M., Turnbull, D. A., Wilson, I. G., & Holtmann, G. J. (2008). Psychological co-morbidity and quality of life (Qol) vary between inflammatory bowel disease (IBD) cohorts in different regions and amongst IBD and other chronic diseases in the one region. In GASTROENTEROLOGY Vol. 134 (pp. A499-A500). W B SAUNDERS CO-ELSEVIER INC. 1997 Cook, C. G., Andrews, J. M., Jones, K. L., Wittert, G. A., Chapman, I. M., Morley, J. E., & Horowitz, M. (1997). Effects of small intestinal nutrient infusion on appetite and pyloric motility are modified by age. In American Journal of Physiology - Regulatory Integrative and Comparative Physiology Vol. 273.
DOI Scopus121 -
Conference Items
Year Citation 2021 Kaazan, P., Ii, T., Seow, W., Bednarz, J., Pipicella, J., Ng, W., . . . Andrews, J. (2021). Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS.
DOI2021 Barnes, A., Krishnaprasad, K., Carter, D., Walsh, A., Grafton, R., Hughes, J., . . . Andrews, J. (2021). Novel inflammatory bowel disease-specific electronic medical record allows scalable auditing of disease severity, therapy, complications, and the unmet need in care. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2020 Kaazan, P., Li, T., Seow, W., Bednarz, J., Pipicella, J., Ng, W., . . . Andrews, J. (2020). Assessing effectiveness and patient perceptions of a novel electronic medical record for the management of inflammatory bowel disease. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2019 Andrews, J. M. (2019). Inflammatory bowel disease in older persons. Poster session presented at the meeting of AUSTRALASIAN JOURNAL ON AGEING. WILEY. 2019 Mikocka-Walus, A., Massuger, W., Knowles, S., Moore, G., Buckton, S., Connell, W., . . . Andrews, J. (2019). Patient experience of the quality of care for people with inflammatory bowel disease in Australia: A national survey. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2019 Davis, R., Day, A., Bryant, R., Andrews, J., Barrett, J., Costello, S., & Vanlint, A. (2019). Habitual dietary fiber and prebiotic intake is inadequate in patients with inflammatory bowel disease. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2019 Hrycek, C., Smart, C., Prosser, R., Lewis, H., Moss, K., Spizzo, P., . . . Mountifield, R. (2019). Consumer acceptability of a bespoke electronic medical record for inflammatory bowel disease is high and privacy concerns are reduced after education. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2018 Lord, A., Mortlock, S., Montgomery, G., Simms, L., Krishnaprasad, K., Hanigan, K., . . . Radford-Smith, G. L. (2018). GENETICALLY DISTINCT SIGNATURES OF MILD AND SEVERE ULCERATIVE COLITIS. Poster session presented at the meeting of GASTROENTEROLOGY. Washington, DC: W B SAUNDERS CO-ELSEVIER INC.
DOI2018 Lord, A., Baird, A., Simms, L., Krishnaprasad, K., Hanigan, K., Doecke, J. D., . . . Lawrance, I. (2018). CROHN'S DISEASE PATIENTS WITH AT LEAST 1 NOD2 MUTATIONS AND WHO SMOKE REGULARLY ARE FOUR TIMES AS LIKELY TO NEED TWO OR MORE RESECTIONS. Poster session presented at the meeting of GASTROENTEROLOGY. Washington, DC: W B SAUNDERS CO-ELSEVIER INC. 2018 Pulusu, S. S. R., Srinivasan, A., Krishnaprasad, K., Cheng, D., Mogilevski, T., Flanagan, E., . . . Lawrance, I. (2018). VEDOLIZUMAB(VDZ) REAL WORLD OUTCOMES IN ULCERATIVE COLITIS (UC). Poster session presented at the meeting of GASTROENTEROLOGY. Washington, DC: W B SAUNDERS CO-ELSEVIER INC. 2018 Hughes, P., Wardill, H., Dmochowska, N., Mavrangelos, C., Campaniello, M., Bowen, J., . . . Andrews, J. (2018). Proteolytic activation of IL-1 beta impairs epithelial barrier integrity in the ulcerative colitis lumen. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Brisbane, Qld: Wiley. 2018 Young, E., Lawrence, M., Thomas, M., & Andrews, J. (2018). Gastrointestinal adenocarcinoma in inflammatory bowel disease (IBD): What does it really "look" like? A retrospective review from a 10-year-old IBD service. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2018 Lord, A. R., Baird, A., Simms, L. A., Hartnell, F., Krishnaprasad, K., Doecke, J., . . . Lawrance, I. C. (2018). Crohn's disease patients with at least one NOD2 mutation and who smoke regularly are four times as likely to need two or more resections. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2018 Lord, A., Mortlock, S., Montgomery, G., Simms, L. A., Krishnaprasad, K., Hanigan, K., . . . Radford-Smith, G. L. (2018). Genetically distinct signatures of mild and severe ulcerative colitis. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY.
DOI2018 Lores, T., Goess, C., Hrycek, C., Grafton, R., Hughes, J., Cronin, L., . . . Andrews, J. (2018). Psychological care is needed and welcomed by patients with inflammatory bowel disease under routine care. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. 2018 Krishnaprasad, K., Walsh, A., Begun, J., Bell, S., Carter, D., Grafton, R., . . . Andrews, J. (2018). Crohn's colitis care (CCCare): development and testing of a bespoke cloud-based clinical management system for inflammatory bowel disease (IBD). Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. 2018 Pulusu, S. S. R., Srinivasan, A., Krishnaprasad, K., Cheng, D., Mogilevski, T., Flanagan, E., . . . Lawrance, I. (2018). Vedolizumab (VDZ) real-world outcomes in ulcerative colitis (UC). Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. 2017 Linedale, E., Mikocka-Walus, A., Gibson, P., & Andrews, J. (2017). Patients’ and clinicians’ views of and experience with a novel clinical pathway for functional gastrointestinal disorders. Poster session presented at the meeting of United European Gastroenterology Journal. Barcelona, Spain: Sage. 2017 Linedale, E., Mikocka-Walus, A., Gibson, P., & Andrews, J. (2017). Performance of a diagnostic algorithm for functional gastrointestinal disorders. Poster session presented at the meeting of United European Gastroenterology Journal. Barcelona, Spain: Sage. 2017 Linedale, E. C., Mikocka-Walus, A., Vincent, A. D., Gibson, P. R., & Andrews, J. M. (2017). Performance of a diagnostic algorithm for functional gastrointestinal disorders. Poster session presented at the meeting of European Medical Journal Gastroenterology. EMG. 2017 Mikocka-Walus, A., Hughes, P., Bampton, P., Gordon, A., Campaniello, M., Mavrangelos, C., . . . Andrews, J. (2017). FLUOXETINE FOR MAINTENANCE OF REMISSION AND TO IMPROVE QUALITY OF LIFE IN PATIENTS WITH CROHN'S DISEASE: A PILOT RANDOMIZED PLACEBO-CONTROLLED TRIAL. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. SAGE PUBLICATIONS LTD. 2017 Mikocka-Walus, A., Bampton, P., Hetzel, D., Hughes, P., Esterman, A., & Andrews, J. (2017). COGNITIVE BEHAVIOURAL THERAPY FOR INFLAMMATORY BOWEL DISEASE: 24-MONTH DATA FROM A RANDOMIZED CONTROLLED TRIAL. Poster session presented at the meeting of AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY. SAGE PUBLICATIONS LTD. 2017 Lores, T., Goess, C., Hrycek, C., Grafton, R., Hughes, J., Cronin, L., . . . Andrews, J. M. (2017). Integrating psychological support into routine care for people with inflammatory bowel disease. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2017 Wardill, H., Bowen, J., Dmochowska, N., Campaniello, M., Mavrangelos, C., Holloway, R., . . . Hughes, P. (2017). Faecal supernatants from diarrhoea predominant Irritable Bowel Syndrome (IBS) patients disrupt colonic epithelial barrier function and directly activate colo-rectal afferent nerves. Poster session presented at the meeting of Abstracts of the NeuroGASTRO 2017 Congress, as published in Neurogastroenterology and Motility. Cork, Ireland: Wiley.
DOI2017 Wen, A., Selvanderan, S. P., Wu, Y., Xuan, W., Andrews, J. M., Koo, J. H., . . . Connor, S. (2017). Assessment of anti-tumor necrosis factor drug levels in people with Crohn's disease changes management decisions more often when done for loss of response than during remission. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY. 2017 Wardill, H. R., Dmochowska, N., Campaniello, M. A., Mavrangelos, C., Bowen, J. M., Andrews, J. M., . . . Hughes, P. A. (2017). Fecal supernatants from active ulcerative colitis patients impair colonic epithelial barrier integrity and activate pelvic mucosal extrinsic afferent nerves. Poster session presented at the meeting of FASEB Journal. Chicago, IL: Federation of American Societies for Experimental Biology. 2017 Bryant, R., Costello, S., Schoeman, S., Sathananthan, D., Lau, S., Schoeman, M., . . . Andrews, J. (2017). P577 "Treat to target" recommendations in ulcerative colitis in practice: clinician perceptions and potential barriers.. Poster session presented at the meeting of J Crohns Colitis. England: Oxford University Press (OUP).
DOI2017 Lawrance, I. C., Baird, A., Lightowler, D., Radford-Smith, G., Andrews, J. M., & Connor, S. (2017). OP007 A multi-centre double blind randomised placebo-controlled study of the use of rectal tacrolimus in the treatment of resistant ulcerative proctitis. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2017 Costello, S., Waters, O., Bryant, R., Katsikeros, R., Makanyanga, J., Schoeman, M., . . . Andrews, J. (2017). OP036 Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2017 Lores, T., Goess, C., Hrycek, C., Grafton, R., Hughes, J., Cronin, L., . . . Andrews, J. M. (2017). P238 Mental health issues and healthcare utilisation in outpatients with inflammatory bowel disease. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2017 Lores, T., Goess, C., Hrycek, C., Grafton, R., Hughes, J., Cronin, L., . . . Andrews, J. (2017). Clinical correlates of mental health issues in outpatients with Inflammatory Bowel Disease in routine care. Poster session presented at the meeting of European Crohn’s & Colitis Organisation’s 12th World Congress. Barcelona, Spain. 2017 Costello, S., Waters, O., Bryant, R., Katsikeros, R., Makanyanga, J., Schoeman, M., . . . Andrews, J. (2017). Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS.
WoS262017 Lores, T., Goess, C., Hrycek, C., Grafton, R., Hughes, J., Cronin, L., . . . Andrews, J. M. (2017). Mental health issues and healthcare utilisation in outpatients with inflammatory bowel disease. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. 2017 Lores, T., Goess, C., Hrycek, C., Grafton, R., Hughes, J., Cronin, L., . . . Andrews, J. M. (2017). Integrated psychological care in outpatients with inflammatory bowel disease. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. 2017 Costello, S., Mashei, C., Bryant, R., Katsikeros, R., Waters, O., Makanyanga, J., . . . Andrews, J. (2017). Comparison of dietary nutrient and food additive intake between patients with moderately active ulcerative colitis, healthy stool donors and the general Australian population. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. 2017 Ben-Horin, S., Andrews, J. M., Katsanos, K. H., Rieder, F., Steinwurz, F., Karmiris, K., . . . Bernstein, C. N. (2017). Combination of corticosteroids and 5-aminosalycilates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: a global survey of physicians' practice. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. 2017 Bryant, R., Costello, S., Schoeman, S., Sathananthan, D., Lau, S., Schoeman, M., . . . Andrews, J. (2017). "Treat to target" recommendations in ulcerative colitis in practice: clinician perceptions and potential barriers. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. 2017 Lores, T. J., Goess, C. S., Grafton, R., Hughes, J., Cronin, L., Mikocka-Walus, A., . . . Andrews, J. M. (2017). Integrated psychological care in Inflammatory Bowel Disease outpatients: Early data from a new initiative.. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF INTEGRATED CARE. UBIQUITY PRESS LTD.
DOI2017 Mavrangelos, C., Campaniello, M., Andrews, J., Bampton, P., & Hughes, P. (2017). Longitudinal analysis of IBS patients reveals that acquired immune responses are inhibited in symptom flare vs symptom free. Poster session presented at the meeting of Abstracts of the NeuroGASTRO 2017 Congress, as published in Neurogastroenterology and Motility. Cork, Ireland: Wiley.
DOI2017 Costello, S. P., Waters, O., Bryant, R. V., Katsikeros, R., Makanyanga, J., Schoeman, M., . . . Andrews, J. M. (2017). SHORT DURATION, LOW INTENSITY, POOLED FECAL MICROBIOTA TRANSPLANTATION INDUCES REMISSION IN PATIENTS WITH MILD-MODERATELY ACTIVE ULCERATIVE COLITIS: A RANDOMISED CONTROLLED TRIAL. Poster session presented at the meeting of GASTROENTEROLOGY. Chicago, IL: W B SAUNDERS CO-ELSEVIER INC.
DOI WoS372016 Goel, G., Mayassi, T., Qiao, S. -W., Ciszewski, C., King, T., Daveson, A. J., . . . Anderson, R. P. (2016). Sa1396 A Single Intradermal (ID) Injection of Nexvax2®, a Peptide Composition With Dominant Epitopes for Gluten-Reactive CD4+ T Cells, Activates T Cells and Triggers Acute Gastrointestinal Symptoms in HLA-DQ2.5+ People With Celiac Disease (CeD). Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2016 Goel, G., Andrews, J. M., Krause, R., Fogel, R., Barish, C. F., Daveson, A. J., . . . Anderson, R. P. (2016). Sa1395 Nexvax2®, a Peptide-Based Antigen-Specific Immunotherapy, Administered Intra-Dermally Three-Times Over 15-Days attenuates Responsiveness to Immuno-Dominant Gluten Peptides in HLA-DQ2.5+ People With Celiac Disease (CeD). Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2016 De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Gorelik, A., Liew, D., . . . Desmond, P. V. (2016). The First Validated Post-Operative Endoscopic Crohns Disease Index: The POCER Index. Identification of Key Endoscopic Prognostic Factors. Poster session presented at the meeting of GASTROENTEROLOGY. San Diego, CA: W B SAUNDERS CO-ELSEVIER INC.
DOI WoS32016 Campaniello, M., Mavrangelos, C., Bampton, P. A., Andrews, J. M., & Hughes, P. A. (2016). Expression of Gut Homing Markers on TReg Differs Between IBS and Remissive IBD. Poster session presented at the meeting of GASTROENTEROLOGY. San Diego, CA: W B SAUNDERS CO-ELSEVIER INC.
DOI2016 Bye, W., Sparrow, M., Connor, S. J., Andrews, J. M., Watson Ng, W. S., Ellard, K., . . . Walsh, A. (2016). Su1831 Identifying “At Risk” Inflammatory Bowel Disease Patients Who May Be Targeted With a New Adjuvanted Herpes Zoster Subunit Vaccine. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2016 De Cruz, P., Kamm, M., Hamilton, A., Ritchie, K., Gorelik, A., Liew, D., . . . Desmond, P. (2016). The first validated post-operative endoscopic Crohn's disease index: the POCER index-identification of key endoscopic prognostic factors. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS.
WoS12016 Grafton, R., Hughes, J., Cronin, L., & Andrews, J. (2016). Proactive triaging of new patients into outpatient clinic improves outcomes at the Royal Adelaide Hospital Inflammatory Bowel Disease Service. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. 2016 Linedale, E. C., Shahzad, M., Mikocka-Walus, A., Gibson, P., & Andrews, J. M. (2016). How Can We Better Manage Functional Gastrointestinal Disease?. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL.
DOI2016 Bryant, R. V., Costello, S. C., Schoeman, S., Sathananthan, D., Lau, S. Y., Schoeman, M. N., . . . Andrews, J. M. (2016). Treat to target' in ulcerative colitis (UC) in the Australian setting: current practice and potential barriers? A multi-site cross-sectional evaluation. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2016 Ferman, M., Hsieh, A. H. C., Brown, M., & Andrews, J. M. (2016). First use of vedoluzimab for steroid dependent immune mediated (ipilimumab) colitis. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2016 Ferman, M., Glen, W. S., Hossain, M., & Andrews, J. M. (2016). Multidisciplinary team meetings: an effective process in managing patients with inflammatory bowel disease. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2016 Bryant, R. V., Costello, S. C., Tee, D., Schoeman, S., Mountifield, R., & Andrews, J. M. (2016). Australian gastroenterologists' perceptions of 'treat to target' recommendations for ulcerative colitis: a survey. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2016 Lores, T., Goess, C., Grafton, R., Hughes, J., Cronin, L., Mikocka-Walus, A., . . . Andrews, J. M. (2016). Routine psychological care in IBD outpatients: early data from a new initiative. Poster session presented at the meeting of 11th Congress of ECCO. Amsterdam, The Netherlands. 2016 Lores, T., Goess, C., Grafton, R., Hughes, J., Cronin, L., Mikocka-Walus, A., . . . Andrews, J. (2016). What is the need for, and acceptability of, routine, integrated psychological care in an established inflammatory bowel disease (IBD) service? Early data from a new initiative in clinical IBD care. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS.
WoS12016 Bye, W., Sparrow, M., Connor, S. J., Andrews, J. M., Ellard, K., Ng, W., . . . Walsh, A. J. (2016). Identifying 'at-risk' inflammatory bowel disease patients who may be targeted with a new adjuvant herpes zoster subunit vaccine. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. 2016 Mikocka-Walus, A., Andrews, J., Bampton, P., Hetzel, D., Hughes, P., & Esterman, A. (2016). Cognitive-behavioural therapy has no effect on disease activity but it improves quality of life in sub-groups of patients with inflammatory bowel disease short-term: a randomised controlled trial with a 24-month follow-up. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS. 2015 Linedale, E., Chur-Hansen, A., Mikocka-Walus, A., Gibson, P., & Andrews, J. (2015). Diagnostic uncertainty signalled by specialists and ongoing investigations may contribute to patient insecurity in functional gastrointestinal disorders. Poster session presented at the meeting of Abstract of the Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015. World Congress of Gastroenterology, as published in Journal of Gastroenterology and Hepatology. Brisbane, Queensland: Wiley-Blackwell.
DOI2015 Linedale, E., Mikocka-Walus, A., Gibson, P., & Andrews, J. (2015). Could a structured screening approach be the answer to the avalanche of functional gastrointestinal disorder referrals? (An interim report). Poster session presented at the meeting of Abstract of the Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015. World Congress of Gastroenterology, as published in Journal of Gastroenterology and Hepatology. Brisbane, Queensland: Wiley-Blackwell.
DOI2015 Rizvi, Q., Linedale, E. C., Mikocka-Walus, A., Gibson, P., & Andrews, J. A. (2015). Do criteria to judge "appropriateness" of endoscopic procedures improve diagnostic yields or allow safe avoidance of upper gastrointestinal endoscopy? A retrospective review. Poster session presented at the meeting of Abstract of the Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015. World Congress of Gastroenterology, as published in Journal of Gastroenterology and Hepatology. Brisbane, Queensland: Wiley-Blackwell.
DOI2015 Rizvi, Q., Linedale, E. C., Mikocka-Walus, A., Gibson, P., & Andrews, J. A. (2015). Can we better target colonoscopies using standard "appropriateness" guides?. Poster session presented at the meeting of Abstract of the Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015. World Congress of Gastroenterology, as published in Journal of Gastroenterology and Hepatology. Brisbane, Queensland: Wiley-Blackwell.
DOI2015 Shahzad, M. A., Linedale, E., Andrews, J. M., & Mikocka-Walus, A. A. (2015). Gastrointestinal outpatients referral quality: safe to use?. Poster session presented at the meeting of Abstract of the Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015. World Congress of Gastroenterology, as published in Journal of Gastroenterology and Hepatology. Brisbane, Queensland: Wiley.
DOI2015 Julsgaard, M., Christensen, L. A., Gibson, P. R., Gearry, R., Fallingborg, J., Kjeldsen, J., . . . Bell, S. J. (2015). Adalimumab and infliximab levels in neonates (ERA study). Poster session presented at the meeting of Abstracts of the 10th Congress of the European Crohn’s and Colitis Organisation (ECCO 2015) as published in Journal of Crohn's and Colitis. Barcelona, Spain: Oxford University Press.
DOI2015 Costello, S., Mashei, C., & Andrews, J. (2015). Comparison of dietary nutrient and food additive intake between patients with moderately active ulcerative colitis and healthy stool donors. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2015 Ooi, S. -Y. J., Gounder, M., Grafton, R., Leach, P., Bampton, P. A., Sechi, A., . . . Andrews, J. M. (2015). Tu1330 Thiopurine Metabolite Testing to Guide Management in Inflammatory Bowel Disease (IBD) Yields Clinical Benefit At 12 Months: A Retrospective Observational Study. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2015) as published in Gastroenterology. Washington, D.C: Elsevier.
DOI2015 Wright, E. K., Kamm, M. A., Selvaraj, F., Princen, F., De Cruz, P., Hamilton, A. L., . . . Singh, S. (2015). Tu1289 Preventing Crohn's Disease Recurrence After Resection With Adalimumab: Role of Drug and Anti-Drug Antibody Levels. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2015 Hamilton, A. L., Kamm, M. A., Selvaraj, F., Princen, F., De Cruz, P., Wright, E. K., . . . Singh, S. (2015). 597 Serological Antibodies for the Prediction of Post-Operative Recurrent Crohn's Disease Results From the POCER Study. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2015 Hamilton, A. L., Kamm, M. A., Selvaraj, F., Princen, F., De Cruz, P., Wright, E. K., . . . Singh, S. (2015). Sa1143 Need for Recurrent Resection and Complex Phenotype Are Associated With a Specific Antibody Signature in Crohn's Disease Patients Undergoing Resection; Smoking Is Not Associated With Prevalent Antibodies; Prognostic and Mechanistic Implications. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2015 Ooi, S. -Y. J., Gounder, M., Grafton, R., Leach, P., Bampton, P. A., Sechi, A., . . . Andrews, J. M. (2015). Tu1331 Are We Under-Recognizing Skewed Thiopurine Metabolism in IBD Patients? Routine Thiopurine Metabolite Measurement Yields Clinical Benefit at 12 Months: A Retrospective Observational Study. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2015 Chen, J. -H., Corte, C. J., Kariyawasam, V. C., Moran, N., Gounder, P., Collins, G. D., . . . Leong, R. W. (2015). Su1102 Consensus Statements on the Management of Acute Severe Ulcerative Colitis. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2015 Julsgaard, M., Christensen, L. A., Gibson, P. R., Gearry, R. B., Fallingborg, J., Kjeldsen, J., . . . Bell, S. (2015). 540 Adalimumab and Infliximab Levels in Neonates (ERA Study). Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2015 Pilichiewicz, A. N., Goess, C., Linedale, E., Ooi, S. J., Bryant, R. V., Grafton, R., . . . Andrews, J. M. (2015). Nutrient intake in patients with inflammatory bowel disease: Are they meeting their dietary requirements?. Poster session presented at the meeting of Abstracts of the Gastro 2015 GESA-AGW and WGO International Congress, Gastroenterological Society of Australia Australian Gastroenterology Week 2015. World Congress of Gastroenterology, as published in Journal of Gastroenterology and Hepatology. Brisbane, Queensland: Wiley.
DOI2014 Wright, E. K., De Cruz, P. P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., . . . Desmond, P. V. (2014). DOP086 Intestinal resection in Crohn's disease is associated with significant and durable improvement in health related quality of life although to a lesser extent in women and smokers. Results from the POCER study. Poster session presented at the meeting of Abstracts of the 9th Congress of the European Crohn’s and Colitis Organisation (ECCO 2014) as published in Journal of Crohn's and Colitis. Copenhagen, Denmark: Oxford University Press.
DOI2014 Kamm, M. A., De Cruz, P. P., Wright, E. K., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., . . . Desmond, P. V. (2014). Optimising post-operative Crohn's disease management: Best drug therapy alone versus endoscopic monitoring, disease evolution, and faecal calprotectin monitoring. The POCER study. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS.
DOI WoS152014 Ghaly, S., Costello, S., Beswick, L., Pudipeddi, A., Agarwal, A., Sechi, A., . . . Andrews, J. (2014). P346 Short term dose tailoring of anti TNF-α therapy delivers useful clinical efficacy in Crohn's disease patients with secondary loss of response. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2014 Wright, E. K., De Cruz, P. P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, E. O., . . . Desmond, P. V. (2014). Faecal calprotectin is superior to faecal lactoferrin and S100A12. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS.
DOI WoS22014 Bennett, A., Moore, D., Bampton, P., & Andrews, J. (2014). P296 What happens to patients with paediatric onset inflammatory bowel disease (IBD) after transition to adult care and what is their view of the process?. Poster session presented at the meeting of Abstracts of the 9th Congress of the European Crohn’s and Colitis Organisation (ECCO 2014) as published in Journal of Crohn's and Colitis. Copenhagen, Denmark: Oxford University Press (OUP).
DOI2014 Costello, S., Ghaly, S., O'Connor, S., Agarwal, A., Beswick, L., Headon, B., . . . Andrews, J. (2014). P529 Compassionate access use of anti-TNF therapy in ulcerative colitis in six Australian IBD centres has been beneficial to patient outcomes. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2014 Wright, E. K., De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, S., . . . Desmond, P. V. (2014). 998 Faecal Calprotectin Is Superior to Faecal Lactoferrin and S100A12 As a Surrogate Marker for Post-Operative Crohn's Disease Endoscopic Recurrence. Prospective Longitudinal Endoscopic Validation. Results From the POCER Study. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2014 Heap, G. A., Singh, A., Bewshea, C. M., Weedon, M., Dubois, P., Andrews, J. M., . . . Ahmad, T. (2014). 6 Thiopurine Induced Pancreatitis in Inflammatory Bowel Disease: Clinical Features and Genetic Determinants. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2014 Bennett, A., Wichmann, M., Andrews, J. M., & Bampton, P. A. (2014). Su1098 Rural and Remote Care for Patients With Inflammatory Bowel Disease -Perceived Barriers Despite Good Non-Expert Practitioner Knowledge. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2014 Ooi, S. -Y. J., Bryant, R. V., Schultz, C. G., Goess, C., Grafton, R., Hughes, J. C., . . . Andrews, J. M. (2014). Mo1265 More Targeted Evaluation of Nutrition in Inflammatory Bowel Disease (IBD) Reveals Opportunities to Optimise Care: Body Mass Index, Body Composition and Iron Deficiency. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2014 Harrington, A. M., Castro, J., Young, R. L., Kurtz, C. B., Silos-Santiago, I., Nguyen, N. Q., . . . Brierley, S. M. (2014). Distinct Alterations in the Guanylate Cyclase-C (GC-C)/Cyclic GMP (cGMP) Pathway Are Evident Across Different Subtypes of Irritable Bowel Syndrome (IBS) Patients. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2014) as published in Gastroenterology. Chicago, Illinois: Elsevier Science Direct.
DOI2014 Pilichiewicz, A. N., Holtmann, G., Goess, C., Holloway, R. H., Fraser, R. J., Beilby, J., . . . Andrews, J. M. (2014). Tu1844 Symptom Stability and Economic Burden in Patients With Functional Dyspepsia: Observational 12 Month Follow-Up After a Short-Term Clinical Trial. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2014 Hughes, P. A., Mikocka-Walus, A. A., Moretta, M., Pilichiewicz, A. N., Bampton, P. A., & Andrews, J. M. (2014). Mo1233 Cognitive Behavioural Therapy (CBT) Influences Innate and Adaptive Inflammatory Responsiveness in IBD Patients With Clinical Remission Sustained Over 6 Months: A Randomised Control Trial. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2014 Elnawsra, O., Fok, I., Connor, S., Sparrow, M., Gibson, P., & Andrews, J. M. (2014). Third party funding for Fecal Calprotectin is likely to reduce colonoscopy usage in Australia: Gastroenterologists' use and knowledge of its role in clinical practice. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2014) as published in Journal of Gastroenterology and Hepatology. Gold Coast, Queensland: Wiley.
DOI2014 Julsgaard, M., Christensen, L. A., Fallingborg, J., Gearry, R., Radford-Smith, G., Walsh, A., . . . Bell, S. J. (2014). DOP041 Intra-uterine ExposuRe to Anti-TNF-alpha therapy (ERA study): Infliximab and adalimumab cord blood levels correlate with maternal levels at birth. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2014 Harrington, A. M., Castro, J., Young, R. L., Kurtz, C. B., Silos-Santiago, I., Nguyen, N. Q., . . . Brierley, S. M. (2014). Distinct Alterations in the Guanylate Cyclase-C (GC-C)/Cyclic GMP (cGMP) Pathway Are Evident Across Different Subtypes of Irritable Bowel Syndrome (IBS) Patients. Poster session presented at the meeting of GASTROENTEROLOGY. Chicago, IL: W B SAUNDERS CO-ELSEVIER INC.
WoS32014 Shah, A., Talley, N. J., Walker, M., Koloski, N., Shanahan, E. R., Morrison, M., . . . Holtmann, G. (2014). Is geographic variability of incidence and prevalence of Crohn's Disease linked to <i>Helicobacter pylori</i>? An ecologic study. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2014 Stephens, M., Hourigan, L. F., Appleyard, M., Ostapowicz, G., Schoeman, M., Desmond, P. V., . . . Holtmann, G. (2014). A systematic review of the performance and cost-efficiency of nurse and non-physician endoscopists. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2014 Bryant, R., Ooi, S., Schultz, C., Goess, C., Grafton, R., Hughes, J., . . . Andrews, J. (2014). Low muscle mass in inflammatory bowel disease (IBD): common and predictive of functional sarcopenia and osteopenia. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS.
DOI2014 Mikocka-Walus, A., Hughes, P., Moretta, M., Pilichiewicz, A., Long, H., Hetzel, D., . . . Andrews, J. (2014). Cognitive-behavioural therapy (CBT) improves inflammatory responsiveness but not mental health short term in IBD patients: A pilot randomised controlled trial. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS.
DOI WoS12014 Bryant, R. V., Ooi, S., Schultz, C., Goess, C., Grafton, R., Hughes, J., . . . Andrews, J. M. (2014). SARCOPAENIA MEASURED BY DXA IS COMMON IN IBD PATIENTS. Poster session presented at the meeting of INTERNAL MEDICINE JOURNAL. WILEY-BLACKWELL. 2014 Harrington, A. M., Castro, J., Young, R. L., Kurtz, C., Silos-Santiago, A., Nguyen, N., . . . Brierley, S. M. (2014). Distinct alterations in the guanylate cyclase-C/cGMP pathway are evident across different subtypes of irritable bowel syndrome patients. Poster session presented at the meeting of Neurogastroenterology and Motility. Guangzhou, China: John Wiley and Sons.
DOI2014 Lim, A. H., Ooi, S. Y., Bryant, R. V., Schultz, C. G., Goess, C., Grafton, R., . . . Andrews, J. M. (2014). The effects of vitamin D deficiency in patients with inflammatory bowel disease. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Broadbeach, Qld.: Wiley.
DOI2014 Julsgaard, M., Christensen, L. A., Lawrence, I., Gearry, R., Connell, W., Grosen, A., . . . Bell, S. J. (2014). Pregnancy outcome and counselling of anti-TNF-alpha treated IBD women: an ongoing international multicentre study. Poster session presented at the meeting of JOURNAL OF CROHNS & COLITIS. OXFORD UNIV PRESS.
DOI WoS12014 Julsgaard, M., Christensen, L. A., Gibson, P. R., Fallingborg, J., Gearry, R., Walsh, A., . . . Bell, S. J. (2014). Adalimumab and Infliximab levels in neonates correlate with duration of treatment in pregnancy (ERA study). Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL.
WoS12013 Mikocka-Walus, A., Andrews, J., von Kaenel, R., & Moser, G. (2013). What are the implications of changing treatment delivery models for inflammatory bowel disease (IBD) sufferers?. Poster session presented at the meeting of PSYCHOTHERAPY AND PSYCHOSOMATICS. Lisboa, PORTUGAL: KARGER. 2013 McCallum, S., Mikocka-Walus, A., Turnbull, D., Gaughwin, M., & Andrews, J. (2013). The role of continuity of care (COC) in the treatment of comorbid mental health and substance use disorders (SUDs): A systematic review of the literature. Poster session presented at the meeting of Abstracts of the Inaugural Conference of the European Association of Psychosomatic Medicine (EAPM 2013) as published in the Journal of Psychosomatic Research. Homerton College, Cambridge, UK: Elsevier.
DOI2013 Hughes, P. A., Moretta, M., Bird, D., Grasby, D., Lim, A., Brierley, S. M., . . . Krumbiegel, D. (2013). Beta-endorphin secretion by monocyte/macrophages is deficient in irritable bowel syndrome: a contributor to visceral hypersensitivity?. Poster session presented at the meeting of NEUROGASTROENTEROLOGY AND MOTILITY. WILEY-BLACKWELL. 2013 Hughes, P., Moretta, M., Lim, A., Grasby, D., Bird, D., Bampton, P., . . . Krumbiegel, D. (2013). Lack of macrophage/monocyte derived β-endorphin contributes toward sensations of pain/discomfort in Irritable Bowel Syndrome. Poster session presented at the meeting of JOURNAL OF IMMUNOLOGY. Honolulu, HI: AMER ASSOC IMMUNOLOGISTS. 2013 Roberts, M. B., Selinger, C. P., Leong, R. W. L., & Andrews, J. M. (2013). Poor Inflammatory Bowel Disease (IBD)-specific pregnancy knowledge in patients with Inflammatory Bowel Disease: predictive factors and implications. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week 2013, as published in Journal of Gastroenterology and Hepatology. Melbourne, Victoria: Wiley-Blackwell.
DOI2013 Rahman, A. H. A., Low, I. W., Chan, F., Rizvi, Q. A., Schoeman, M. N., Harley, H. A. J., . . . Holloway, R. H. (2013). Urgent endoscopy for oesophageal variceal bleeding: does it matter?. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2013) as published in the Journal of Gastroenterology and Hepatology. Melbourne, Victoria: Wiley. 2013 Costello, S., Ghaly, S., Beswick, L., Pudipeddi, A., Agarwal, A., Headon, B., . . . Andrews, J. M. (2013). Compassionate access use of Anti-TNF therapy in Ulcerative Colitis in four Australian IBD centres has been beneficial to patient outcomes. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2013 Ghaly, S., Costello, S., Beswick, L., Pudipeddi, A., Agarwal, A., Sechi, A., . . . Andrews, J. M. (2013). Compassionate access use of anti-TNF therapy in Crohn's disease reduces the need for steroids in an Australian multicenter retrospective review. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2013 Lunney, P., Kariyawasam, V., Middleton, K., Wang, R., Huang, T., Selinger, C., . . . Leong, R. (2013). P614 Smoking prevalence and its effects on disease course and surgery in a cohort of inflammatory bowel disease patients from Sydney, Australia. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2013 Mikocka-Walus, A., & Andrews, J. (2013). P320 What's the evidence-base for treating mental health co-morbidities in IBD?. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2013 Roberts, M., Selinger, C., Leong, R., & Andrews, J. (2013). P586 Assessment of pregnancy-specific inflammatory bowel disease (IBD) knowledge, attitudes and experience in Australian obstetricians and gynaecologists (O&G). Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2013 Bryant, R., Schultz, C., Grafton, R., Hughes, J., Goess, C., Schoeman, M., . . . Andrews, J. (2013). P375 Sarcopaenia in inflammatory bowel disease (IBD), a prominent finding in males with normal BMI: What are we missing?. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2013 Lawrance, I., Murray, K., Batman, B., Gearry, R., Grafton, R., Krishnaprasad, K., . . . Hanigan, K. (2013). P365 Smoking and the effect of its cessation on Crohn's disease progression and surgical rates. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2013 Hughes, J., Andrews, J., & Grafton, R. (2013). N004 Successful, nurse-led, protocol-based, safety monitoring in IBD patients on thiopurines. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2013 Kariyawasam, V., Lunney, P., Huang, T., Middleton, K., Wang, R., Selinger, C., . . . Leong, R. (2013). P631 Natural history of elderly onset inflammatory bowel disease – Sydney IBD Cohort (1942–2012). Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2013 Kariyawasam, V. C., Lunney, P. C., Huang, T. D., Middleton, K., Wang, R. R., Selinger, C. P., . . . Leong, R. W. (2013). 39 Early Treatment With Immunomodulators Is Associated With Change in the Natural History of Inflammatory Bowel Disease - Multicentre Longitudinal Study -Sydney, Australia 1942-2012. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2013 De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Krejany, S., Gorelik, A., . . . Desmond, P. (2013). 925j Optimising post-operative Crohn's disease management: best drug therapy alone versus colonoscopic monitoring with treatment step-up. The POCER study.. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2013 Bryant, R. V., Schultz, C. G., Grafton, R., Hughes, J. C., Goess, C., Schoeman, M., . . . Andrews, J. M. (2013). Mo1311 Body Mass Index (BMI) Is Better At Predicting Fat Mass Than Muscle Mass in Inflammatory Bowel Disease (IBD) Patients. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2013 Pilichiewicz, A. N., Andrews, J. M., Goess, C., Holloway, R. H., Fraser, R. J., Beilby, J., . . . Holtmann, G. (2013). Mo1871 A 12 Month Follow-up of Patients Complying With ROME III Criteria for FD: Symptom Stability and Economic Burden. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2013 Pan, W. -J., Radford-Smith, G., Andrews, J. M., Schwartz, H. I., Sullivan, B. A., Evangelista, C. M., . . . Borie, D. C. (2013). Sa1207 Pharmacokinetics/Pharmacodynamics (PK/PD), Efficacy, and Safety of AMG 181 in Subjects With Active, Mild to Moderate Ulcerative Colitis - An Initial Assessment. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2013 Kashkooli, S., Roberts, M. B., Selinger, C. P., Weston, M. J., Andrews, J. M., & Leong, R. W. (2013). Mo1279 Pregnancy-Related Inflammatory Bowel Disease Knowledge Amongst Obstetricians Is Significantly Lower Than Gastroenterologists. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2013 Mountifield, R. E., Bampton, P. A., Prosser, R., Bobridge, A., Mikocka-Walus, A. A., & Andrews, J. M. (2013). Mo1962 FIT+ and IBD Individuals Have Differing Psychological Reactions to the Need for Colonoscopy. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2013 Harrington, A. M., Castro, J., Young, R. L., Kurtz, C. B., Silos-Santiago, A., Nguyen, N. Q., . . . Brierley, S. M. (2013). 268 Alterations in the Guanylate Cyclase-C/cGMP Pathway in Patients With Irritable Bowel Syndrome With Constipation. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2013 Holtmann, G., Andrews, J. M., Holloway, R. H., Beilby, J., Adam, B., Pilichiewicz, A. N., . . . Talley, N. J. (2013). Mo2071 A Placebo Controlled Randomised Treatment Trial for Functional Dyspepsia Including Post-Treatment Drug Withdraw and Placebo Withdraw Effects. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2013 Mikocka-Walus, A. A., Andrews, J. M., Von Kanel, R., & Moser, G. (2013). 246 What are the implications of changing treatment delivery models for inflammatory bowel disease (IBD) sufferers?. Poster session presented at the meeting of Abstracts of the 22nd World Congress on Psychosomatic Medicine: Psychosomatic Assessment and Integrative Care (ICPM 2013)as published in Psychotherapy and Psychosomatics. Karger Publishers. 2013 De Cruz, P., Kamm, M., Hamilton, A., Ritchie, K., Krejany, S., Gorelik, A., . . . Desmond, P. (2013). Strategic timing of anti-TNF therapy in postoperative Crohn's disease: Comparison of routine use immediately postoperatively with selective use after demonstrated recurrence at 6 month endoscopy. Results from POCER. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2013) as published in Journal of Gastroenterology and Hepatology. Melbourne, Australia: Wiley.
DOI2013 De Cruz, P., Kamm, M., Hamilton, A. L., Ritchie, K. J., Krejany, S., Gorelik, A., . . . Desmond, P. (2013). Smoking is the key risk factor that doubles the risk of postoperative recurrence of Crohn's disease despite preventive drug treatment. Results from the POCER study. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2013), as published in Journal of Gastroenterology and Hepatology. Melbourne, Australia: Wiley.
DOI2013 Bennett, A., Wichmann, M. W., Andrews, J. M., & Bampton, P. A. (2013). Rural IBD patients' access to care, rural surgeons' and IBD nurses' perspectives: Good practitioner knowledge, but significant barriers to optimal care. Poster session presented at the meeting of Abstracts of Journal of Australian Gastroenterology Week (AGW 2019) as published in Gastroenterology and Hepatology. Melbourne, Australia: Wiley. 2013 Julsgaard, M., Christensen, L. A., Gearry, R., Andrews, J. M., Rosella, O., Connor, S., . . . Bell, S. J. (2013). Intra-uterine exposure to anti-TNF-alpha therapy (ERA study): Neonatal levels of TNF antibodies correlate with duration of therapy in pregnancy. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2013) as published in Journal of Gastroenterology and Hepatology. Melbourne, Australia: Wiley.
DOI2012 Lunney, P. C., Middleton, K. L., Wang, R. R., Andrews, J. M., Kariyawasam, V. C., Peat, J., . . . Leong, R. W. (2012). Smoking prevalence in inflammatory bowel disease and its effects on disease course and surgery. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley.
DOI2012 Kariyawasam, V. C., Wang, R. R., Middleton, K. L., Lunney, P. C., Selinger, C. P., Collins, G. D., . . . Leong, R. W. (2012). Surgical resection rate of Crohn's disease over time: the Sydney Inflammatory Bowel Disease Cohort (1942-2012). Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley.
DOI2012 Kariyawasam, V. C., Middleton, K. L., Lunney, P. C., Wang, R. R., Andrews, J. M., Selinger, C. P., . . . Leong, R. W. (2012). The natural history of ulcerative colitis and predictors of the use of immunomodulators and colectomy: the Sydney Inflammatory Bowel Disease Cohort 1946-2012. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley.
DOI2012 Kariyawasam, V. C., Lunney, P. C., Wang, R. R., Middleton, K. L., Selinger, C. P., Katelaris, P., . . . Leong, R. W. (2012). Natural history of Crohn's disease and changes in the use of immunomodulators over time: the Sydney inflammatory bowel disease cohort 1942-2012. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley.
DOI2012 Agarwal, A., & Andrews, J. M. (2012). IBD-related pyoderma gangrenous in the biologic era: a single centre, 5-year case series and systematic literature review. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley.
DOI2012 De Cruz, P., Kamm, M., Hamilton, A. L., Ritchie, K., Gorelik, A., Liew, D., . . . Desmond, P. V. (2012). P342 Adalimumab prevents post-operative Crohn's disease recurrence and is superior to thiopurines: Early results from the prospective POCER study. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2012 Mikocka-Walus, A., Gordon, A., Stewart, B., & Andrews, J. M. (2012). P271 A magic pill? Patients' views on the role of antidepressant therapy in inflammatory bowel disease (IBD). Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2012 Selinger, C., Andrews, J. M., Dent, O., & Leong, R. (2012). P082 Survival over >20 years in a large Australian metropolitan cohort of inflammatory bowel disease patients: No excess overall mortality. Poster session presented at the meeting of Abstracts of the 7th Congress of the European Crohn’s and Colitis Organisation (ECCO 2012) as published in Journal of Crohn's and Colitis. Barcelona, Spain: Oxford University Press (OUP).
DOI2012 Hartnell, F., Jones, L., Bampton, P., Krishnaprasad, K., Grafton, R., Cooke, S., . . . Radford-Smith, G. (2012). P372 Predicting long-term response to anti-TNFα in Crohn's disease. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2012 De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Gorelik, A., Liew, D., . . . Desmond, P. (2012). Su2092 Clinical Risk Stratification Predicts Development of Endoscopic Recurrence After Crohn's Disease Surgery: Early Results From the POCER Study. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2012 Pilichiewicz, A. N., Andrews, J. M., Goess, C., McMahon, J., Barrett, B., Fraser, R. J., . . . Holtmann, G. (2012). Su1633 Placebo Effects in Functional Dyspepsia: A Preliminary Analysis on Symptoms in an Ongoing Randomized Placebo Controlled Trial. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2012 Pilichiewicz, A. N., Persson, J., Goess, C., Gapasin, J. D., Tsopelas, C., Bartholomeusz, D., . . . Andrews, J. M. (2012). Sa2068 The Effect of the Probiotic Escherichia coli Nissle 1917 on Symptom Patterns and Immune Response in Patients Suffering From Diarrhoea Predominant Irritable Bowel Syndrome. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2012 Huynh, D., Bate, J. P., Andrews, J. M., Johnson, R., LeMire, M., Nind, G., & Harley, H. A. (2012). Mo1890 Prevalence and Phenotype of Inflammatory Bowel Disease in Patients With Primary Sclerosing Cholangitis. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2012 Radford-Smith, G., Hartnell, F., Jones, L. V., Krishnaprasad, K., Prosser, R., Marr, D., . . . Gearry, R. B. (2012). Sa1921 Predicting Long-Term Response to Anti-TNF Therapy in Crohn's Disease. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2012 Radford-Smith, G., Krishnaprasad, K., Andrews, J. M., Bampton, P. A., Simms, L., Mahy, G., . . . Lawrance, I. C. (2012). Sa1282 Colectomy for Ulcerative Colitis Across Australia and New Zealand: Indications, Risk Factors and Rates - an ANZ IBD Consortium Study. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2012 Hughes, P. A., Bird, D., Brierley, S. M., Persson, J., Moretta, M., Blackshaw, L. A., . . . Andrews, J. M. (2012). TNF-alpha from gut homing memory T cells and monocytes sensitises colonic sensory afferents in IBS-D. Poster session presented at the meeting of Neurogastroenterology and Motility: Supplement. Bologna, Italy: WILEY-BLACKWELL. 2012 Wright, E., Andrews, J. M., Bampton, P. A., Moore, D., Williams, J., Lemberg, D. A., . . . De Cruz, P. (2012). Perspectives on transfer and transition care of adolescents with inflammatory bowel disease (IBD) from paediatric to adult care: a survey of paediatric and adult gastroenterologists in Australia and New Zealand. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley. 2012 Selinger, C. P., Andrews, J. M., Titman, A. C., & Leong, R. W. (2012). The natural history of Crohn's disease: need for initial and further resectional surgery. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley.
DOI2012 Selinger, C. P., Andrews, J. M., Titman, A. C., & Leong, R. W. (2012). Low incidence of colorectal cancer in Australian ulcerative colitis patients. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley.
DOI2012 Middleton, K. L., Kariyawasam, V. C., Lunney, P. C., Wang, R. R., Selinger, C. P., Katelaris, P., . . . Leong, R. W. (2012). A comparison of inflammatory bowel disease patients aged with disease and those diagnosed late in life. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2012) as published in Journal of Gastroenterology and Hepatology. Adelaide, South Australia: Wiley.
DOI2012 Pilichiewicz, A. N., Holtmann, G., Goess, C., Holloway, R., Fraser, R. J., Beilby, J., . . . Andrews, J. (2012). Symptoms and disease burden in patients with functional dyspepsia: an observational 12 month follow-up. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2012 Mikocka-Walus, A., Turnbull, A., Holtmann, G., & Andrews, J. (2012). THE INTEGRATED MODEL OF CARE FOR INFLAMMATORY BOWEL DISEASE SUFFERERS IN AUSTRALIA: THE DEVELOPMENT OF THE PROTOCOL AND THE EFFECTS OF ITS IMPLEMENTATION. Poster session presented at the meeting of INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE. SPRINGER. 2012 Rahman, A. H. A., Hrycek, C., Bryant, R. V., Andrews, J., Nguyen, N., Schoeman, M., & Holloway, R. (2012). Is there a 'weekend effect' among patients referred to a dedicated 'haematemesis and melaena' service?. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Adelaide, SA: Wiley.
DOI2012 Kashkooli, S. B., Selinger, C., Weston, M. J., Roberts, M. B., Andrews, J., Leong, R. W., & Akbarzadeh, S. (2012). Pregnancy-related inflammatory bowel disease knowledge amongst obstetricians is significantly lower than gastroenterologists. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2012 Roberts, M. B., Selinger, C., Leong, R. W., & Andrews, J. (2012). Assessment of pregnancy-specific inflammatory bowel disease (IBD) knowledge, attitudes and experience in obstetricians and gynaecologists. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2012 Hughes, P., Nicholson, I., Bird, D., To, S., Isaacs, N., Grasby, D., . . . Krumbiegel, D. (2012). C-IBS patients lack monocyte derived β-endorphin which results in disinhibition of colonic afferent mechanosensitivity. Poster session presented at the meeting of Gastroenterology. USA: WB Saunders.
DOI2011 Hughes, P., Harrington, A., Brierley, S., Maldeniya, M., Martin, C., Persson, J., . . . Blackshaw, L. (2011). Cytokine modulation of visceral afferents via cation channels is switched in chronic visceral hypersensitivity. Poster session presented at the meeting of Gastroenterology. Chicago, IL: W B Saunders Co.
DOI2011 Williamson, K. D., Andrews, J. M., Clark, M., & Harley, H. (2011). INPATIENT HEALTH CARE UTILISATION ALCOHOLIC LIVER DISEASE: WHAT ARE THE COSTS AND OUTCOMES?. Poster session presented at the meeting of JOURNAL OF HEPATOLOGY. Berlin, GERMANY: ELSEVIER.
DOI2011 Persson, J., Pilichiewicz, A. A., Gapasin, J., Goess, C., Holtmann, G. J., Holloway, R., & Andrews, J. M. (2011). Immune response in patients with diarrhoea predominant irritable bowel syndrome following Escherichia coli Nissle 1917, mutaflor treatment. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2011 Pilichiewicz, A. N., Persson, J., Goess, C., Gapasin, J., Holtmann, G. J., Holloway, R. H., & Andrews, J. M. (2011). The effect of the probiotic Escherichia coli Nissle 1917 on symptom patterns in patients suffering from diarrhoea predominant irritable bowel syndrome. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL. 2011 Pilichiewicz, A. N., Andrews, J. M., Goess, C., Mcmahon, J., Fraser, R. J., Beilby, J., . . . Holtmann, G. (2011). A preliminary analysis of the effect Iberogast®, Nexium, dual Iberogast® plus Nexium or dual placebo on symptoms in patients with functional dyspepsia. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL.
WoS22011 Asser, T. L., Kennedy, N. A., Bampton, P. A., Andrews, J. M., Elliott, D., & Doogue, M. (2011). The effect of allopurinol on thiopurine metabolite concentrations in patients with inflammatory bowel disease. Poster session presented at the meeting of Abstracts of the 6th Congress of the European Crohn’s and Colitis Organisation (ECCO 2011). Dublin, Ireland: ECCO. 2011 Kennedy, N. A., Doogue, M., Andrews, J. M., Asser, T. L., & Bampton, P. A. (2011). P268. Thiopurine metabolite measurement and the management of inflammatory bowel disease in South Australia: The first 18 months. Poster session presented at the meeting of 6th Congress of ECCO. Dublin. 2011 De Cruz, P., Kamm, M. A., Hamilton, A. L., Ritchie, K. J., Prideaux, L., Lawrance, I. C., . . . Connell, W. (2011). Prospective evaluation of early post-operative Crohn's recurrence in the presence of optimal drug therapy - Is Endoscopic Evaluation Worthwhile?. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2011) as published in Gastroenterology. Chicago, IL: Elsevier.
DOI2011 Haag, S., Andrews, J. M., Gapasin, J. D., Keller, A., & Holtmann, G. (2011). The influence of socioeconomic status on the prevalence of upper gastrointestinal symptoms: a 13-Nation Population Survey. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2011) as published in Gastroenterology. Chicago, IL: Elsevier.
DOI2011 Lawrance, I. C., Batman, B., Gearry, R., Grafton, R., Krishnaprasad, K., Andrews, J. M., . . . Croft, A. (2011). Smoking cessation following the diagnosis of Crohn's Disease still reduces the rates of surgery and complicated disease. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2011), as published in Gastroenterology. Chicago, IL: Elsevier.
DOI WoS12011 Mikocka-Walus, A. A., Turnbull, D. A., Holtmann, G., & Andrews, J. M. (2011). Coping with the unmet needs of gastroenterology and hepatology outpatients: a systematic approach towards an integrated model of care in South Australia. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2011) as published in Gastroenterology. Chicago, IL: Elsevier.
DOI WoS22011 Mountifield, R. E., Moseley, A., Prosser, R., Mikocka-Walus, A. A., Young, G., Andrews, J. M., & Bampton, P. A. (2011). Colonoscopic bowel cancer screening is associated with more depression and anxiety in previously healthy people than those with inflammatory bowel disease. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2011) as published in Gastroenterology. Chicago, IL: Elsevier.
DOI WoS12011 Williamson, K. D., Andrews, J. M., Clark, M., & Harley, H. (2011). 507 INPATIENT HEALTH CARE UTILISATION ALCOHOLIC LIVER DISEASE: WHAT ARE THE COSTS AND OUTCOMES?. Poster session presented at the meeting of Journal of Hepatology. Elsevier BV.
DOI2011 Walker, N. M., Andrews, J. M., Walsh, A. J., & Radford-Smith, G. (2011). Ulcerative colitis management: a survey on current practice by Australian gastroenterologists. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2011) as published in Journal of Gastroenterology and Hepatology. Brisbane Convention & Exhibition Centre, Australia: Wiley.
DOI2011 Selinger, C. P., Bath, S., Andrews, J. M., Dent, O., & Leong, R. W. (2011). Mortality in a large Australian metropolitan cohort of Crohn's disease patients. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2011) as published in Journal of Gastroenterology and Hepatology. Brisbane Convention & Exhibition Centre, Australia: Wiley.
DOI2011 Williamson, K. D., Andrews, J. M., Clark, M., & Harley, H. (2011). Inpatient health care utilisation in alcoholic liver disease: what are the costs and outcomes?. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Brisbane, Qld: Wiley.
DOI2010 mikocka-Walus, A. A., Bond, M., Holloway, R. H., Burke, A. L. J., Collins, K., Blackshaw, L. A., . . . Andrews, J. A. (2010). Does Cognitive Behavioural Therapy (CBT) Improve Outcomes in Inflammatory Bowel Disease (IBD). Poster session presented at the meeting of European Crohn’s and Colitis Organisation, 5th ECCO Congress, Inflammatory Bowel Diseases. Prague, Czech republic. 2010 Mikocka-Walus, A. A., Bond, M., Holloway, R. H., Persson, J., Pilichiewicz, A. N., Hughes, P. A., . . . Andrews, J. M. (2010). T1253 Does Cognitive-Behavioural Therapy (CBT) Improve Outcomes in Inflammatory Bowel Disease (IBD)? Initial Feasibility Report on a Pilot Randomised Controlled Trial. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2010 Van Langenberg, D. R., & Andrews, J. M. (2010). W1319 Predictors of Suboptimal Medication Adherence in IBD Patients: A Single Australian Tertiary Centre Experience. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2010 Paterson, J., Grafton, R., Van Langenberg, D. R., & Andrews, J. M. (2010). 761 The Effect of Perianal Disease on Perceived Severity of Crohn's Disease (CD). Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2010 Pilichiewicz, A. N., Holtmann, G., Persson, J., Gapasin, J., Holloway, R. H., Goess, C., . . . Andrews, J. M. (2010). S1339 A Double-Blind, Randomized, Cross-Over Study on the Effects of STW5 on Symptoms and Immunologic Function in Patients With Irritable Bowel Syndrome. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2010 Gururatsakul, M., Andrews, J. M., Holtmann, G., Talley, N., & Holloway, R. H. (2010). T1089 Symptomatic Uncomplicated Peptic Ulcer Disease: True Peptic Ulcer or Functional Dyspepsia?. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2010 Phan, V. -A., van Langenberg, D. R., Grafton, R., & Andrews, J. M. (2010). M1037 Introduction of a Dedicated IBD Service Quantitatively and Qualitatively Improves Outcomes in Less Than 18 Months: A Prospective Cohort Study in a Large Metropolitan Centre. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2010 Mikocka-Walus, A. A., van Langenberg, D. R., Holtmann, G., & Andrews, J. M. (2010). S1016 Psychogastroenterology: A Biopsychosocial Approach to Treating Inflammatory Bowel Disease (IBD). Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2010 Sack, C., Phan, V. A., Grafton, R., Van Langenberg, D. R., Holtmann, G., & Andrews, J. M. (2010). The introduction of a formal IBD service reduces healthcare utilisation and disease burden indicators (complexity measures) in IBD patients. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. 2010 Pilichiewicz, A. N., Holtmann, G., Goess, C., Mcmahon, J., Fraser, R. J., Beilby, J., . . . Andrews, J. M. (2010). Recruiting to a functional dyspepsia clinical trial:-where have all the patients gone?. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. 2010 Andrews, J. M., Oster, C., Grafton, R., Hetzel, D. J., & Lawrence, M. (2010). Inflammatory Bowel Disease (IBD) patients' assessment and regulation of their diet in relation to symptom recurrence. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. 2010 Haag, S., Andrews, J. M., Gapasin, J., Gerken, G., Keller, A., & Holtmann, G. (2010). A 13-nation population survey of upper gastrointestinal symptoms: the impact of socioeconomic status. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. 2010 Andrews, J. M., Oster, C., Grafton, R., Hetzel, D. J., & Lawrence, M. (2010). The importance of patient perception of personalised care in the provision of specialist care for patients with Inflammatory Bowel Disease (IBD). Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. 2010 Stewart, B. J., Mikocka-Walus, A., Harley, H., Morgan, J., Colman, A., Phelps, M., & Andrews, J. M. (2010). Psychosocial and mental health issues surrounding chronic hepatitis C: patient, hepatologist and counsellor perspectives. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. 2010 Mikocka-Walus, A., Holtmann, G., & Andrews, J. (2010). A South Australian integrated model of care for Inflammatory Bowel Disease. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. 2010 Mikocka-Walus, A. A., Bond, M., Holloway, R. H. H., Pilichiewicz, A., Persson, J., Collins, K., . . . Andrews, J. M. (2010). Cognitive behavioural therapy (CBT) as a treatment modality in inflammatory bowel disease (IBD): early experience and preliminary results. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. 2010 Doecke, J., Simms, L. A., Zhao, Z. Z., Huang, N., Hanigan, K., Croft, A., . . . Radford-Smith, G. L. (2010). Genetic susceptibility in IBD: overlap between ulcerative colitis and Crohn's disease. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC.
WoS12010 Crocker, K. M., Chur-Hansen, A., Bampton, P., & Andrews, J. M. (2010). A comparison of sexual dysfunction in functional bowel disorders and inflammatory bowel disease: does the diagnosis make a difference to patients?. Poster session presented at the meeting of Abstracts of Australian Gastroenterology Week (AGW 2010) as published in the Journal of Gastroenterology and Hepatology. Gold Coast, Queensland: Wiley. 2009 Andrews, J. M., Mikocka-Walus, A. A., Hetzel, D. J., & Holtmann, G. (2009). P113 - Interactions among treatment trends, quality of life and disease activity in inflammatory bowel disease (IBD). Poster session presented at the meeting of Abstracts of the 4th Congress of the European Crohn’s and Colitis Organisation (ECCO 2009) as published in Journal of Crohn's and Colitis. Hamburg, Germany: Oxford University Press (OUP).
DOI2009 Gapasin, J., van Langenberg, D. M., Holtmann, G., Hetzel, D. J., & Andrews, J. M. (2009). P172 - In what proportion of IBD patients coming to resection surgery was there an opportunity to optimise preoperative care? A one year audit of a tertiary referral hospital. Poster session presented at the meeting of Journal of Crohn's and Colitis. Oxford University Press (OUP).
DOI2009 Zschau, N. B., Andrews, J. M., Holloway, R. H., Schoeman, M., Lange, K., Tam, W., & Holtmann, G. (2009). M1912 Do Socioeconomic Status and Lifestyle Factors Predict Symptomatic Improvement Over 8 Weeks in Patients with Gastroesophageal Reflux Symptoms in the Routine Clinical Setting? - the MAPSOMAL Study. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2009 Knott, V. E., Holtmann, G., Turnbull, D. A., & Andrews, J. M. (2009). M1253 Patients' Satisfaction with Specialist Gastroenterologist Consultation for Irritable Bowel Syndrome (IBS)and Health Care Utilisation: Exploring the Role of Patient Expectations. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2009 Mountifield, R. E., Bampton, P. A., Prosser, R., Muller, K. R., & Andrews, J. M. (2009). S1118 Pregnancy, Disease Activity and IBD Medication: This Two-Edged Sword from a Patient Perspective. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2009 Van Langenberg, D. R., Bryant, R. V., Holtmann, G., & Andrews, J. M. (2009). S1034 Symptoms of Functional Gastrointestinal Disorders (FGIDs) in IBD Patients and the Inter-Relationships of Psychological Co-Morbidity, Quality of Life and Disease Activity. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2009 Lawrance, I. C., Bampton, P. A., Sparrow, M., Gearry, R. B., Leong, R. W., Andrews, J. M., . . . Florin, T. H. (2009). S1102 Serious Infective Complications in Anti-TNFα Treated Inflammatory Bowel Disease Patients. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2009 Haag, S., Andrews, J. M., Gapasin, J. D., Keller, A., & Holtmann, G. (2009). 970 A 13-Nation Population Survey of Upper Gastrointestinal Symptoms: Age and Gender. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2009 Adam, B., Liebregts, T., Zschau, N. B., Faraguna, L. -A., Gapasin, J. D., Andrews, J. M., . . . Holtmann, G. (2009). T1266 Z-338 Improves Meal-Induced Symptoms in Functional Dyspepsia: A Double-Blind, Randomized, Placebo Controlled Crossover Study. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2009 Zschau, N. B., Holtmann, G., Holloway, R. H., Schoeman, M., Lange, K., Tam, W., & Andrews, J. M. (2009). M1852 Do Concomitant Functional Dyspepsia and Irritable Bowel Syndrome Influence Changes in Quality of Life in Patients with Gastroesophageal Reflux Symptoms Referred for Endoscopy? - the MAPSOMAL Study. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2009 Farrall, E., Collins, J., Turnbull, D. A., Holtmann, G., Hetzel, D. J., & Andrews, J. M. (2009). M1249 Do We Know What Patients Want? the Communication/Understanding Gap Between Patients with Functional Gastrointestinal Disorders (FGIDs) and Gastroenterologists. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2009 Alshumrany, M. A., Van Langenberg, D. R., Holtmann, G., Hetzel, D. J., & Andrews, J. M. (2009). W1111 Comparative Complexity of Crohn's Disease (CD) Compared to Ulcerative Colitis (UC) in a Metropolitan Hospital Setting. Effects of Gender and Disease Activity. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2008 Mountifield, R. E., Prosser, R., Bampton, P. A., & Andrews, J. M. (2008). W1136 Fear and Fertility in Inflammatory Bowel Disease - A Mismatch of Perception and Reality Affects Patient Behaviour. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2008) as published in Gastroenterology. San Diego, California: Elsevier Science Direct.
DOI2008 Zschau, N. B., Tam, W., Andrews, J. M., Holloway, R. H., Schoeman, M., & Holtmann, G. J. (2008). T2015 Multivariate Analysis of Predictors for Severity of Mucosal Lesions in Patients with GERD Symptoms (Mapsomal): A Clinical, Epidemiological and Endoscopic Survey. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2008) as published in Gastroenterology. San Diego, California: Elsevier.
DOI2008 Mikocka-Walus, A. A., Andrews, J. M., Turnbull, D. A., Wilson, I. G., & Holtmann, G. J. (2008). T1172 Psychological Co-Morbidity and Quality of Life (Qol) Vary Between Inflammatory Bowel Disease (IBD) Cohorts in Different Regions and Amongst IBD and Other Chronic Diseases in the One Region. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2008 Knott, V. E., Andrews, J. M., Turnbull, D. A., & Holtmann, G. J. (2008). T1025 IBS and Outpatient Services: Towards the Development of An Empirical Model of Health Care Utilisation. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2008 Muller, K. R., Prosser, R., Bampton, P. A., & Andrews, J. M. (2008). 944 Female Gender and Surgery Lead to Greater Perceived Impact of Inflammatory Bowel Disease (IBD) On Body Image and Sexual Function: A Neglected Issue. Poster session presented at the meeting of Gastroenterology. Elsevier BV.
DOI2008 Steveling, K., Holtmann, G. J., Schoeman, M., & Andrews, J. M. (2008). Appropriateness and Diagnostic Yield of Colonoscopy in Young Women. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2008), as published in Gastrointestinal Endoscopy. San Diego, California: Mosby.
DOI2008 Andrews, J. M., Mikocka-Walus, A. A., Turnbull, D. A., Hetzel, D. J., & Holtmann, G. J. (2008). T1171 Concomitant Symptoms of Functional Gastrointestinal Disorders (FGIDs) in Patients with Inflammatory Bowel Disease (IBD) Are Associated with Decreased Quality of Life (Qol). Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2008), as published in Gastroenterology. San Diego, California: Elsevier.
DOI2008 Van Langenberg, D. R., Lange, K., Hetzel, D. J., Holtmann, G., & Andrews, J. M. (2008). Psychiatric comorbidities and prior surgery are associated with poorer outcomes in IBD patients. Poster session presented at the meeting of Proceedings of the 2008 Australian Gastroenterology Week, as published in Journal of Gastroenterology and Hepatology. Brisbane, QLD: Wiley.
DOI2008 Lawrance, I. C., Bampton, P. A., Sparrow, M., Gearry, R. B., Leong, R. W., Andrews, J. M., . . . Radford-Smith, G. L. (2008). Serious infective complications associated with anti-TNF alpha therapy in inflammatory bowel disease. Poster session presented at the meeting of Abstracts of the Australian Gastroenterology Week (AGW 2008) as published in Journal of Gastroenterology and Hepatology. Brisbane, Australia: Wiley.
WoS22008 Bertram, S., Van Langenberg, D. R., Holtmann, G., & Andrews, J. M. (2008). Do inflammatory bowel disease (IBD) responders differ from nonresponders to a postal questionnaire? Implications for generalisability. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC.
WoS12008 Langenberg, V., Simon, S. J., Holtmann, G., & Andrews, J. M. (2008). IBD patients and healthcare utilisation: gastroenterologists do make a difference!. Poster session presented at the meeting of Abstracts of Australian Gastroenterology Week (AGW 2008) as published in Journal of Gastroenterology And Hepatology. Brisbane, Australia: Wiley. 2008 Farrall, E., Collins, J., Turnbull, D. A., Hetzel, D. J., Holtmann, G., & Andrews, J. M. (2008). Do we know what patients want? The under-recognised needs of patients with functional gastrointestinal disorders (FGID). Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. 2008 Mikocka-Walus, A. A., Turnbull, D. A., Andrews, J. M., Moulding, N. T., Wilson, I. G., & Holtmann, G. J. (2008). Does psychological status influence clinical outcomes in patients with inflammatory bowel disease (IBD) and other chronic gastroenterological diseases: an observational cohort prospective study. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY-BLACKWELL PUBLISHING, INC. 2006 Mikocka-Walus, A., Turnbull, D., Andrews, J., Holtmann, G., Moulding, N., & Wilson, I. (2006). Do antidepressants have an impact on the course of inflammatory bowel disease?. Poster session presented at the meeting of AUSTRALIAN JOURNAL OF PSYCHOLOGY. TAYLOR & FRANCIS LTD. 2006 Mountifield, R. E., Andrews, J. M., Fraser, R. J., Heddle, R., Hebbard, G. S., & Checklin, H. (2006). How does age affect manometric diagnosis in patients with dysphagia?. Poster session presented at the meeting of Abstracts of Australian Gastroenterology Week (AGW 2006), as published in Journal of Gastroenterology and Hepatology. Adelaide, Australia: Wiley.
DOI2001 Andrews, J. M., O'Donovan, D. G., Hebbard, G. S., Doran, S. M., Malbert, C. H., & Dent, J. (2001). Human duodenal phase III MMC activity is not predominantly retroperistaltic. Poster session presented at the meeting of Abstracts of Digestive Disease Week (DDW 2001) and the 102nd Annual Meeting of the American Gastroenterological Association, as published in Gastroenterology. Atlanta, G.A: Elsevier.
DOI2000 Jones, K. L., Berry, M. K., Andrews, J., MacIntosh, C., & Horowitz, M. (2000). Effects of cisapride on antral area and fullness during intraduodenal lipid infusion. Poster session presented at the meeting of Gastroenterology. San Diego, CA: Elsevier.
DOI1998 Andrews, J. M., Rayner, C. K., Doran, S. M., & Horowitz, M. (1998). Variations of blood glucose in the physiological range alter appetite, gastrointestinal sensation, and pyloric motility. Poster session presented at the meeting of Abstracts of the American Gastroenterological Association and Digestive Disease Week (DDW 1998) as published in Gastroenterology. New Orleans, Louisiana: Elsevier.
DOI1998 Verhaaen, M. A. M. T., Rayner, C. K., Andrews, J. M., Doran, S. M., Hebbard, G. S., Samsom, M., & Horowitz, M. (1998). Effect of physiological changes in blood glucose on proximal gastric motor and sensory function. Poster session presented at the meeting of Abstracts of the Netherlands Society of Gastroenterology and the Netherlands Society of Hepatology: Spring Meeting, 19–20 March 1998. Lippincott Williams.
DOI
| Date | Project Title | Role | Funding Body | Amount |
|---|---|---|---|---|
| 2016 | Exploring the role of diet as an Adjunctive Therapy in Ulcerative Colitis (EAT-UC Study) | CIC | RAH Research Foundation | $18,640 |
| 2015-17 | Faecal Microbiota Transplantation for Active Ulcerative Colitis - a randomised controlled trial: clinical, microbial and immune outcomes | CIA | NHMRC | $765,896 |
| 2015-16 | Psychological care in routine IBD practice | CIA | GESA/Janssen | $125,000 |
| 2014-16 | FMT in ulcerative colitis | CIA | GUTSY Foundation | $150,000 |
| 2013-15 | Immune function in functional GI disorders | AI | NHMRC | $454,369 |
| 2013-14 | Low dose fluoxetine in Crohn’s disease | CIB | Broad Foundation US | $128,000 |
| 2013-14 | RIBG | CIA | RAH Research Foundation | $67,000 p.a |
| 2013 | Transition Care Outcomes of Paediatric patients with IBD After Entering Adult Medical care | CIA | Abbott Australia | $40,000 |
| 2013 | IBD disease Burden in Rural and Remote Patients | CIB | Janssen Australia | $50,000 |
| 2012-14 | Genomic medicine: Predictors of refractory ulcerative colitis and its response to treatment | CID | NHMRC | $849,263 |
| 2012 | CBT in IBD study | CIA | Abbott Australia | $50,000 |
| 2010-11 | Does Cognitive Behavioural Therapy (CBT) prolong remission in IBD? | CIB | Crohn’s and Colitis Australia | $150,000 |
| 2009 | Investigation of factors influencing patient satisfaction or dissatisfaction with medical and surgical care in IBD | CIA | RAH | $20,000 |
- Accredited Supervisor, Examiner and Site Visitor for Advanced Training in Gastroenterology, Royal Australian College of Physicians 2006-current
- Coordinator of undergraduate and postgraduate teaching within clinical gastroenterology & hepatology @ RAH 2009-current
- Clinical Ward Teaching, Gastroenterology Unit 4-6th year University of Adelaide Undergraduate Medical Students, 2007-present & coordinator of GE afternoon core program 2009-current
-
Current Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2023 Co-Supervisor The impact of obesity and adiposity on inflammatory bowel disease Master of Clinical Science Master Part Time Dr Patricia Kaazan 2022 Co-Supervisor Psychological and Psychosocial Factors associated with Prehabilitation Drop-out and Completion amongst Bariatric Surgery Candidates Doctor of Philosophy Doctorate Full Time Miss Mia Majstorovic -
Past Higher Degree by Research Supervision (University of Adelaide)
Date Role Research Topic Program Degree Type Student Load Student Name 2021 - 2024 Principal Supervisor Defining and validating the role of intestinal ultrasound for assessment of inflammatory bowel disease Doctor of Philosophy Doctorate Full Time Dr Tom Goodsall 2020 - 2022 Co-Supervisor Gut microbiome insights into the pathophysiology of inflammatory bowel disease Doctor of Philosophy Doctorate Full Time Miss Gina Lucille Guzzo 2018 - 2021 Principal Supervisor Exploring a patient-centred, diet-focused treatment paradigm for Inflammatory Bowel Disease Doctor of Philosophy Doctorate Full Time Mrs Alice Sarah Day 2015 - 2018 Principal Supervisor Improving Quality of Care in Inflammatory Bowel Disease: Treatment Targets and Body Composition Doctor of Philosophy Doctorate Full Time Prof Rob Venning Bryant 2014 - 2016 Principal Supervisor Optimising Care for Patients with Inflammatory Bowel Disease: Rural Patients' Burden of Disease and Perceived Treatment Barriers: Outcomes of Transition Care and Evaluation of Simple Clinical Tools for Outpatient Management of Ulcerative Colitis Master of Philosophy (Medical Science) Master Full Time Mrs Alice Louise Nottle 2013 - 2017 Principal Supervisor Issues in the Diagnosis and Management of Functional Gastrointestinal Disorders: The Development of a Novel Clinical Pathway Doctor of Philosophy Doctorate Full Time APrf Ecushla Claire Linedale 2013 - 2019 Principal Supervisor Faecal Microbiota Transplantation for the Treatment of Active Ulcerative Colitis Doctor of Philosophy Doctorate Full Time APrf Samuel Paul Costello 2012 - 2015 Co-Supervisor The progression and management of depression and anxiety in chronic hepatitis C patients Doctor of Philosophy/Master of Psychology (Clinical) Doctorate Full Time Mr Benjamin James Robert Stewart 2012 - 2016 Co-Supervisor Three Studies Investigating Quality Indicators for the Treatment of Substance Use Disorders and Comorbidity: Continuity of Care, Treatment Need and Patient Satisfaction Doctor of Philosophy/Master of Psychology (Clinical) Doctorate Full Time Miss Stacey Lee McCallum 2005 - 2008 Co-Supervisor Six Studies Pointing to the Need for a Biopsychosocial Approach to Treating Common Gastrointestinal and Hepatologic Disorders Doctor of Philosophy Doctorate Full Time Prof Antonina Mikocka-Walus
-
Board Memberships
Date Role Board name Institution name Country 2014 - ongoing Board Member Crohn's Colitis Cure Charity Australia 2013 - ongoing Advisory Board Member Vedolizumab Australian Advicory Board Vedolizumab Australia 2012 - 2013 Advisory Board Member Vital Foods Advisory Board Vital Foods - 2011 - ongoing Advisory Board Member Remicade Advisory Board Janssen - 2009 - ongoing Advisory Board Member Humira Advisory Board Abbott & AbbVie Australia 2009 - ongoing Advisory Board Member IBD Advisory Board Ferring Australia 2009 - 2011 Advisory Board Member Remicade Advisory Board MSD - 2006 - 2009 Advisory Board Member Remicade Advisory Board Schering Plough - 2005 - 2007 Advisory Board Member Colazide Advisory Board Pharmacia Fresenius Kabi Australia -
Committee Memberships
Date Role Committee Institution Country 2008 - ongoing Member Research Ethics Committee Royal Adelaide Hospital Australia -
Memberships
Date Role Membership Country 2013 - ongoing Member Australian Association of Consultant Physicians - 2008 - ongoing Member European Crohn's & Colitis Organisation (ECCO) - 2000 - ongoing Member American Gastroenterological Association United States 2000 - ongoing Member Australian IBD Association (within GESA) - 1994 - ongoing Member Royal Australasian College of Physicians Australia 1992 - ongoing Member Gastroenterological Society of Australia - 1986 - ongoing Member Australia Medical Association - -
Offices Held
Date Office Name Institution Country 2017 - 2019 Chair SPC AGW 2018-2019 GESA Australia 2017 - 2019 Board Member GESA GESA Australia
Connect With Me
External Profiles
